First Participant Dosed with Acoramidis in ACT-EARLY, the First Ever ATTR Primary Prevention Study
- - ATTRibute-CM, BridgeBio's Phase 3 clinical trial of acoramidis in patients with ATTR-CM, achieved statistical significance in reducing the risk of ACM or first CVH versus placebo in ATTRv-CM patients (59.1% risk reduction) , establishing the mechanistic hypothesis that stabilizing TTR may delay or prevent ATTRv-CM
- 05/13/2025
|
Aduro Clean Technologies Engages Generation IACP to Provide Market Making Services
- LONDON, Ontario, May 13, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc . (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced that it has entered into an agreement effective May 12th, 2025 (the “Agreement”) with Generation IACP Inc. (“Generation”) to provide market making services in accordance with Canadian Securities Exchange (CSE) policies.
- 05/13/2025
|
Aduro Clean Technologies and Cleanfarms Sign Memorandum of Understanding to Collaborate on Development of Commercial Pathway for Challenging Agricultural Plastics
- LONDON, Ontario, May 08, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc . (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced the signing of a Memorandum of Understanding (“MOU”) with Cleanfarms Inc. (“Cleanfarms”), which is known as AgriRÉCUP in Quebec.
- 05/08/2025
|
Actinium Announces Enrollment of First Patient in the Iomab-ACT Commercial CAR-T Trial at the University of Texas Southwestern Medical Center
- - Initial clinical data expected in the second half of 2025 from this first-of-its-kind trial to administer a targeted radiotherapy conditioning agent with a commercial CAR-T therapy - Iomab-ACT supported by results of NIH funded trial with MSK showing effective lymphodepletion of targeted immune cells resulting in negligible rates of CAR-T toxicities ICANS and CRS and CAR T-cell persistence with a novel CD19 CAR-T therapy - Iomab-ACT has the potential to increase the addressable market for CAR-T therapies, which generated $4 billion in sales in 2024, by enabling improved access and better patient outcomes compared to current chemotherapy conditioning agents NEW YORK , May 6, 2025 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced that the first patient was enrolled on the trial studying Iomab-ACT targeted conditioning with a commercial CAR-T therapy at the University of Texas Southwestern Medical Center (UTSW) (NCT06768905). Initial clinical data from this trial is expected in the second half of 2025.
- 05/06/2025
|
4 Stocks to Watch That Recently Declared Dividend Hikes Amid Volatility
- Stocks like ATKR, ACT, POOL and AWK recently announced dividend hikes.
- 05/02/2025
|
Enact Holdings, Inc. (ACT) Q1 2025 Earnings Call Transcript
- Enact Holdings, Inc. (NASDAQ:ACT ) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ET Company Participants Daniel Kohl - Vice President of Investor Relations Rohit Gupta - President and Chief Executive Officer Dean Mitchell - Chief Financial Officer Conference Call Participants Mihir Bhatia - Bank of America Merrill Lynch Douglas Harter - UBS Richard Shane - JPMorgan Chase & Co. Bose George - Keefe, Bruyette, & Woods, Inc. Operator Hello, and welcome to Enact's First Quarter Earnings Call. Please be advised that today's conference is being recorded.
- 05/02/2025
|
Aduro Engages Siemens to Deliver Advanced Automation for Hydrochemolytic™ Pilot Plant
- LONDON, Ontario, May 01, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower-value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, announced today a strategic collaboration with Siemens Canada , a leader in industrial automation and digitalization, to supply advanced control systems and engineering services for Aduro's Next Generation Process Pilot Plant (the “Pilot Plant”), scheduled for commissioning in Q3 2025. At the core of the solution is Siemens' SIMATIC PCS neo distributed control system—an advanced, web-based platform that will provide centralized, secure, and scalable process control for the continuous operation of the Pilot Plant.
- 05/01/2025
|
Enact Holdings, Inc. (ACT) Lags Q1 Earnings and Revenue Estimates
- Enact Holdings, Inc. (ACT) came out with quarterly earnings of $1.10 per share, missing the Zacks Consensus Estimate of $1.12 per share. This compares to earnings of $1.04 per share a year ago.
- 04/30/2025
|
Enact Reports First Quarter 2025 Results
- GAAP Net Income of $166 million , or $1.08 per diluted share Adjusted Operating Income of $169 million , or $1.10 per diluted share Return on Equity of 13.1% and Adjusted Operating Return on Equity of 13.4% Primary Insurance in-force of $268 billion , a 2% increase from first quarter 2024 PMIERs Sufficiency of 165% or approximately $2.0 billion Book Value Per Share of $33.96 and Book Value Per Share excluding AOCI of $34.97
- 04/30/2025
|
Enact Announces 14% Increase to Quarterly Dividend and New $350 Million Share Repurchase Program
- RALEIGH, N.C., April 30, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) announced that its Board of Directors declared a quarterly dividend of $0.21 per common share, an increase of 14% from the prior quarter's dividend. This dividend will be payable on June 11, 2025, to shareholders of record on May 19, 2025.
- 04/30/2025
|
Blue Bird Showcases Zero- and Low-Emission Commercial Vehicle Platforms at 2025 Advanced Clean Transportation (ACT) Expo
- MACON, Ga.--(BUSINESS WIRE)--Blue Bird Corporation (Nasdaq: BLBD), the leader in electric and low-emission school buses, showcases its latest zero- and ultra-low emission commercial vehicle platforms at the upcoming 2025 Advanced Clean Transportation (ACT) Expo, North America's largest advanced transportation technology event. The company presents both its groundbreaking electric step van and propane-powered stripped chassis at the industry event from April 28-30, 2025, at the Anaheim Conventio.
- 04/29/2025
|
Enact Holdings, Inc. (ACT) Reports Next Week: Wall Street Expects Earnings Growth
- Enact Holdings (ACT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/23/2025
|
Electrovaya to Showcase New Battery Products at the Advanced Clean Transportation (ACT) Expo 2025
- Electrovaya's Latest Battery Modules and Battery Systems that will be Manufactured in the USA will be on display at the ACT EXPO from April 28-30th at the Anaheim Convention Center TORONTO, ON / ACCESS Newswire / April 22, 2025 / Electrovaya Inc. (NASDAQ:ELVA)(TSX:ELVA), a leading lithium-ion battery technology and manufacturing company, announces that that it will be exhibiting at the Advanced Clean Transportation ("ACT") Expo2025, taking place on April 28 - April 30, 2025, at the Anaheim Convention Center in California, USA. Electrovaya will be exhibiting at Booth #3421 , where it will be showcasing its latest lithium ion battery cells, modules and battery systems which will be manufactured at scale at its gigafactory in Jamestown, New York.
- 04/22/2025
|
Phoenix Motors To Participate in the Advanced Clean Transportation (ACT) Expo at Anaheim Convention Center
- ANAHEIM, CA / ACCESS Newswire / April 16, 2025 / Phoenix Motor Inc. dba PhoenixEV (NASDAQ:PEV), a leading manufacturer of heavy-duty transit buses and electrification solutions provider for medium-duty vehicles, is excited to announce its participation in the Advanced Clean Transportation (ACT) Expo, taking place from April 28 to May 1 at the Anaheim Convention Center. This prestigious event brings together industry leaders, innovators, and key stakeholders dedicated to advancing transportation solutions that prioritize sustainability and environmental responsibility.
- 04/16/2025
|
Enact to Host First Quarter 2025 Earnings Call May 1st
- RALEIGH, N.C., April 10, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) announced it will issue its first quarter earnings release after the market closes on April 30, 2025. Enact will host a conference call to review first quarter 2025 financial results on May 1, 2025 at 8:00 a.m. (ET).
- 04/10/2025
|
Enact Holdings Set to Join S&P SmallCap 600
- NEW YORK , April 9, 2025 /PRNewswire/ -- Enact Holdings Inc. (NASD: ACT) will replace SolarWinds Corp. (NYSE: SWI) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, April 16. Turn/River Capital is acquiring SolarWinds in a deal expected to close soon, pending final closing conditions.
- 04/09/2025
|
Tritium CEO Announces Revolutionary DC Fast Charging Solution to be Unveiled at ACT Expo
- Arcady Sosinov, appointed Tritium CEO in December 2024, announces a next-generation ultra-scaling EV charging solution that will be revealed April 28, 2025 at ACT Expo in Anaheim, Calif. Arcady Sosinov, appointed Tritium CEO in December 2024, announces a next-generation ultra-scaling EV charging solution that will be revealed April 28, 2025 at ACT Expo in Anaheim, Calif.
- 04/08/2025
|
Enact Releases 2024 Sustainability Report
- RALEIGH, N.C., March 28, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) today announced the release of its 2024 Sustainability Report covering the calendar year 2024.
- 03/28/2025
|
Are Finance Stocks Lagging Enact Holdings (ACT) This Year?
- Here is how Enact Holdings, Inc. (ACT) and Erie Indemnity (ERIE) have performed compared to their sector so far this year.
- 03/14/2025
|
Enact Announces Changes to its Board of Directors
- RALEIGH, N.C., March 11, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) today announced that it has appointed H.
- 03/11/2025
|
Seven & i in talks with Couche-Tard over store sales for merger deal
- Japan's Seven & i Holdings said on Monday that talks have begun with Canada's Alimentation Couche-Tard (ACT) over a store sale plan that would set the stage for ACT's $47 billion takeover bid.
- 03/09/2025
|
Aduro Clean Technologies Appoints Vice President of Finance
- LONDON, Ontario, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc . (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced the appointment of Neha Nisar (“Neha”) as Vice President of Finance.
- 02/27/2025
|
Aduro Clean Technologies to Participate in Key Industry Conferences
- LONDON, Ontario, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, is pleased to announce its participation in a series of key industry conferences. With the expected commissioning of the Company's Next Generation Process (“NGP”) Pilot Plant in the third quarter of 2025, Aduro will take advantage of the opportunity to present the unique features of the process and share its plans with key stakeholders.
- 02/18/2025
|
ACT or GSHD: Which Is the Better Value Stock Right Now?
- Investors with an interest in Insurance - Multi line stocks have likely encountered both Enact Holdings, Inc. (ACT) and Goosehead Insurance (GSHD). But which of these two stocks is more attractive to value investors?
- 02/14/2025
|
ACT-ion Raises $7.5 million in Pre-Series A Round Led by BASF Venture Capital
- DALLAS, Feb. 10, 2025 (GLOBE NEWSWIRE) -- ACT-ion Battery Technologies, a startup in the field of lithium ion battery cathode active materials (CAM), announced today the successful closing of its Pre-Series A funding round. Founded in 2019, ACT-ion has developed both an efficient and cost-effective means to produce single crystalline cathode active materials.
- 02/10/2025
|
Enact Holdings, Inc. (ACT) Q4 2024 Earnings Conference Call Transcript
- Enact Holdings, Inc. (NASDAQ:ACT ) Q4 2024 Earnings Conference Call February 5, 2025 8:00 AM ET Company Participants Daniel Kohl - Vice President, Finance & Investor Relations Rohit Gupta - President & Chief Executive Officer Dean Mitchell - Chief Financial Officer & Treasurer Conference Call Participants Bose George - KBW Doug Harter - UBS Operator Hello, and welcome to Enact's Fourth Quarter Earnings Call. Please be advised that today's conference is being recorded.
- 02/05/2025
|
Enact Holdings, Inc. (ACT) Q4 Earnings and Revenues Lag Estimates
- Enact Holdings, Inc. (ACT) came out with quarterly earnings of $1.09 per share, missing the Zacks Consensus Estimate of $1.11 per share. This compares to earnings of $0.98 per share a year ago.
- 02/04/2025
|
Enact Reports Fourth Quarter and Full Year 2024 Results and Announces Quarterly Dividend
- GAAP Net Income of $163 million , or $1.05 per diluted share Adjusted Operating Income of $169 million , or $1.09 per diluted share Return on Equity of 13.0% and Adjusted Operating Return on Equity of 13.5% Record Primary insurance in-force of $269 billion , a 2% increase from fourth quarter 2023 PMIERs Sufficiency of 167% or $2,052 million Book Value Per Share of $32.80 and Book Value Per Share excluding AOCI of $34.16 Returned over $350 million of capital to shareholders in 2024 Announces quarterly cash dividend of $0.185 per common share
- 02/04/2025
|
INTEGRA HIGHLIGHTS IDAHO'S SPEED ACT TO SUPPORT PERMITTING EFFICIENCY, NEW FEDERAL INITIATIVES, AND REITERATES COMMITMENT TO ADVANCING PERMITTING AT DELAMAR
- TSXV: ITR; NYSE American: ITRG www.integraresources.com VANCOUVER, BC , Jan. 30, 2025 /PRNewswire/ - Integra Resources Corp. ("Integra" or the "Company") (TSXV: ITR) (NYSE American: ITRG) is pleased to offer its strong support for Idaho Governor Brad Little's Executive Order 2025-02, the Strategic Permitting, Efficiency, and Economic Development Act (the "SPEED Act" or the "Act"). The recently signed executive order creates a SPEED Council, comprised of Idaho state agency directors, to streamline collaboration across state agencies and expedite the review of state permits for development projects across all sectors in a coordinated manner.
- 01/30/2025
|
Enact Mortgage Insurance Enters into Two Forward XOL Reinsurance Transactions as Part of its Diversified Credit Risk Transfer Program
- Secures approximately $225 million and $260 million of excess of loss reinsurance coverage from a panel of third-party reinsurance providers Secures approximately $225 million and $260 million of excess of loss reinsurance coverage from a panel of third-party reinsurance providers
- 01/27/2025
|
Enact Receives Ratings Upgrades from Fitch Ratings
- RALEIGH, N.C., Jan. 21, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact), a leading provider of private mortgage insurance through its insurance subsidiaries, today announced that Fitch Ratings (“Fitch”) upgraded the insurance financial strength rating for our flagship insurance subsidiary, Enact Mortgage Insurance Corporation, to A from A-.
- 01/21/2025
|
Enact to Host Fourth Quarter 2024 Earnings Call February 5th
- RALEIGH, N.C., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) announced it will issue its fourth quarter earnings release after the market closes on February 4, 2025. Enact will host a conference call to review fourth quarter 2024 financial results on February 5, 2025 at 8:00 a.m. (ET).
- 01/09/2025
|
Aduro Clean Technologies to Host Virtual Fireside Chat on Thursday, January 23rd, 2025
- LONDON, Ontario, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc . (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced it will host a virtual fireside chat for shareholders on Thursday, January 23rd, 2025 at 4:30 pm ET.
- 01/09/2025
|
The New Year May Not Be Kind To Radian Group
- The New Year May Not Be Kind To Radian Group
- 12/31/2024
|
Here's Why Enact Holdings (ACT) is Poised for a Turnaround After Losing -8.06% in 4 Weeks
- Enact Holdings (ACT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
- 12/24/2024
|
Aduro Clean Technologies Announces Second Partial Exercise of Over-Allotment Option
- LONDON, Ontario, Dec. 11, 2024 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21ˢᵗ century, today announced that the underwriters of its underwritten U.S. public offering (the “Offering”) have, for a second time, partially exercised their over-allotment option to purchase an additional 22,470 common shares at the public offering price of US$4.25 per share. After giving effect to the partial exercise of the over-allotment option, the Company sold an aggregate 1,063,647 common shares for gross proceeds of approximately US$4.52 million, before deducting underwriter discounts and other related expenses.
- 12/11/2024
|
$500,000 ACT Grant Awarded to Fund Newport News Public Schools' New Teacher Institute Program
- Four leading companies partner in support of education and workforce development mission NEWPORT NEWS, Va. , Dec. 11, 2024 /PRNewswire/ -- Today, the BayPort Foundation, Ferguson, Newport News Shipbuilding, a division of HII, and Virginia Natural Gas announced that the Newport News Education Foundation has been awarded the $500,000 Accelerating Change Together (ACT) Grant to support the Newport News Public Schools (NNPS) New Teacher Institute (NTI) program.
- 12/11/2024
|
Aduro Clean Technologies Announces Partial Exercise of Over-Allotment Option
- LONDON, Ontario, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced that the underwriters of its underwritten U.S. public offering (the “Offering”) have partially exercised their over-allotment option to purchase an additional 100,000 common shares at the public offering price of US$4.25 per share. After giving effect to the partial exercise of the over-allotment option, the Company sold an aggregate 1,041,177 common shares for gross proceeds of approximately US$4.43 million, before deducting underwriter discounts and other related expenses.
- 12/03/2024
|
Enact Mortgage Insurance Enters into Two Quota Share Reinsurance Agreements
- Secures 27% of forward quota share reinsurance coverage from a panel of third-party reinsurance providers Secures 27% of forward quota share reinsurance coverage from a panel of third-party reinsurance providers
- 12/03/2024
|
Aduro Clean Technologies Announces Voting Results for Election of Directors
- LONDON, Ontario, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc . (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, is pleased to announce that at its 2023/2024 annual general meeting held November 22, 2024 (the “Meeting”), all of the nominees for election as directors of the Company referred to in its notice of meeting and information circular dated October 23, 2024 for the Meeting were elected.
- 12/02/2024
|
Aduro Clean Technologies Announces Closing of US$4 Million Uplisting to Nasdaq
- LONDON, Ontario, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced the closing of its underwritten U.S. public offering (the “Offering”) of 941,177 common shares at a public offering price of US$4.25 per common share. The common shares commenced trading on the Nasdaq Capital Market on November 7, 2024, under the ticker symbol “ADUR.
- 11/08/2024
|
Enact Holdings, Inc. (ACT) Q3 2024 Earnings Call Transcript
- Enact Holdings, Inc. (NASDAQ:ACT ) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Daniel Kohl - Vice President, Finance & Investor Relations Rohit Gupta - President & Chief Executive Officer Dean Mitchell - Chief Financial Officer & Treasurer Conference Call Participants Doug Harter - UBS Mihir Bhatia - Bank of America Bose George - KBW Richard Shane - JPMorgan Operator Good day and welcome to the Enact Third Quarter 2024 Earnings Conference Call. All participants will be in listen-only mode.
- 11/08/2024
|
Aduro Clean Technologies Announces Pricing of US$4 Million Uplisting to Nasdaq
- LONDON, Ontario, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced the pricing of its underwritten U.S. public offering of 941,177 common shares at a public offering price of US$4.25 per common share for aggregate gross proceeds of approximately US$4 million, prior to deducting underwriting discounts and offering expenses (the “Offering”). In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 141,176 common shares at the public offering price, less underwriting discounts to cover over-allotments, if any.
- 11/07/2024
|
Enact Holdings, Inc. (ACT) Q3 Earnings and Revenues Top Estimates
- Enact Holdings, Inc. (ACT) came out with quarterly earnings of $1.16 per share, beating the Zacks Consensus Estimate of $1.01 per share. This compares to earnings of $1.02 per share a year ago.
- 11/06/2024
|
Enact Reports Third Quarter 2024 Results And Announces Quarterly Dividend
- GAAP Net Income of $181 million, or $1.15 per diluted share Adjusted Operating Income of $182 million, or $1.16 per diluted share Return on Equity of 14.7% and Adjusted Operating Return on Equity of 14.8% Record Primary insurance in-force of $268 billion, a 2% increase from third quarter 2023 PMIERs Sufficiency of 173% or $2,190 million Book Value Per Share of $32.61 and Book Value Per Share excluding AOCI of $33.27 Announces quarterly cash dividend of $0.185 per common share
- 11/06/2024
|
Enact Holdings, Inc. (ACT) Expected to Beat Earnings Estimates: Should You Buy?
- Enact Holdings (ACT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 10/30/2024
|
Why Enact Holdings (ACT) Could Beat Earnings Estimates Again
- Enact Holdings (ACT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 10/10/2024
|
Strategist discusses ACT's raised $47 billion bid for 7-Eleven owner Seven & i
- Nicholas Smith, Japan strategist at CLSA, says Seven & i's restructuring plans may be a case of "too little too late."
- 10/10/2024
|
Enact to Host Third Quarter 2024 Earnings Call November 7th
- RALEIGH, N.C., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) announced it will issue its third quarter earnings release after the market closes on November 6, 2024. Enact will host a conference call to review third quarter 2024 financial results on November 7, 2024 at 8:00 a.m. (ET).
- 10/08/2024
|
Is Enact Holdings (ACT) Outperforming Other Finance Stocks This Year?
- Here is how Enact Holdings, Inc. (ACT) and Arch Capital Group (ACGL) have performed compared to their sector so far this year.
- 09/25/2024
|
7-Eleven owner rejects $38bn takeover bid as it ‘grossly undervalues' business
- 7-Eleven's Japanese owner Seven & i has formally rejected a takeover bid tabled by Canadian convenience store giant Alimentation Couche-Tard Inc (TSX:ATD.B) (ACT). ACT, which owns the Circle K chain, announced the surprise $38 billion bid in August, in what would have been the largest takeover of a Japanese corporate in history.
- 09/06/2024
|
PRIMO WATER AND BLUETRITON BRANDS ANNOUNCE EXPIRATION OF THE WAITING PERIOD UNDER THE HSR ACT
- TAMPA, Fla. and STAMFORD, Conn.
- 09/05/2024
|
Enact Provides Update on Capital Position Under New PMIERs Available Asset Guidelines
- RALEIGH, N.C., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact), a leading provider of private mortgage insurance through its insurance subsidiaries, today addressed the updated Private Mortgage Insurer Eligibility Requirements (PMIERs) released by Fannie Mae and Freddie Mac (the GSEs), and the Federal Housing Finance Administration (FHFA) on August 21, 2024 which will be phased-in between March 31, 2025 and September 30, 2026.
- 08/21/2024
|
Enact Re, Ltd. Receives A- Rating from S&P Global Ratings
- First Rating Assigned to Enact Re by S&P and Second Rating Since Launch Underscores Continued Strong Performance First Rating Assigned to Enact Re by S&P and Second Rating Since Launch Underscores Continued Strong Performance
- 08/19/2024
|
CSE Bulletin: Consolidation - Aduro Clean Technologies Inc. (ACT)
- Toronto, Ontario--(Newsfile Corp. - Le 19 août/August 2024) - Aduro Clean Technologies Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every three and one quarter (3.25) pre-consolidated common shares. As a result, the outstanding shares of the company will be reduced to approximately 27,174,297 common shares.
- 08/19/2024
|
New Strong Buy Stocks for August 7th
- GRC, HGTY, APOG, AER and ACT have been added to the Zacks Rank #1 (Strong Buy) List on August 7, 2024.
- 08/07/2024
|
Actinium Expands Patent Coverage Over Iomab-ACT, its Next-Generation Targeted Radiotherapy Conditioning Agent, for Gene Edited Stem Cell-Based Therapies for Non-Malignant Indications
- - Newly issued U.S. patent augments Actinium's existing composition of matter patent coverage over Iomab-B and Iomab-ACT targeted radiotherapy conditioning programs - Pertains to the use of Iomab-ACT with genetically engineered hematopoietic stem cells for treating non-malignant diseases including sickle cell disease, severe combined immunodeficiency disease, β-thalassemia and Fanconi's anemia NEW YORK , Aug. 1, 2024 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of Antibody Radiation Conjugates (ARCs) and other targeted radiotherapies, today announced the issuance of U.S. Patent No. 11,912,780 titled, "Anti-CD45-Based Conditioning Methods and Uses Thereof in Conjunction with Gene-Edited Cell Based Therapies" by the United States Patent and Trademark Office (USPTO).
- 08/01/2024
|
Enact Holdings, Inc. (ACT) Surpasses Q2 Earnings Estimates
- Enact Holdings, Inc. (ACT) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.03 per share. This compares to earnings of $1.10 per share a year ago.
- 07/31/2024
|
Enact Reports Second Quarter 2024 Results and Announces Quarterly Dividend
- GAAP Net Income of $184 million , or $1.16 per diluted share Adjusted Operating Income of $201 million , or $1.27 per diluted share Return on Equity of 15.4% and Adjusted Operating Return on Equity of 16.9% Record Primary insurance in-force of $266 billion , a 3% increase from second quarter 2023 PMIERs Sufficiency of 169% or $2,057 million Book Value Per Share of $30.91 and Book Value Per Share excluding AOCI of $32.43 Announces quarterly cash dividend of $0.185 per common share
- 07/31/2024
|
Actinium Announces FDA Clearance of Iomab-ACT Targeted Conditioning IND Application for Sickle Cell Disease Patients Undergoing Bone Marrow Transplant in Collaboration with Columbia University
- - Sickle cell disease affects approximately 100,000 patients in the U.S. annually and is a debilitating and life-threatening condition with high unmet need - Current conditioning with non-targeted chemotherapies provides limited access to potentially curative bone marrow transplant and recently approved gene therapies for sickle cell disease patients - Initial trial focused on conditioning for bone marrow transplant intended to inform subsequent gene therapy conditioning study and provide broader access to cellular therapy for sickle cell patients NEW YORK , July 25, 2024 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of Antibody Radiation Conjugates (ARCs) and other targeted radiotherapies, today announced the FDA clearance of an Investigational New Drug (IND) application to study Iomab-ACT for targeted conditioning prior to a bone marrow transplant (BMT), in patients with sickle cell disease. The study will be conducted in collaboration with the Columbia University and led by Markus Mapara, M.D.
- 07/25/2024
|
Enact Holdings, Inc. (ACT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
- Enact Holdings (ACT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/24/2024
|
Enact Holdings: Defensive Play In A Corner Of The Housing Market
- Enact Holdings, a mortgage insurance company, has outperformed the S&P 500 index over a two-year period in spite of low mortgage originations. However, the pace of gains has slowed, and the companies competing in the mortgage insurance sector all appear fairly valued at this time. Enact has shareholder-friendly management with a growing dividend and share repurchases, however opportunity for organic appreciation in the shares may be limited in the near term.
- 07/21/2024
|
Can Enact Holdings (ACT) Keep the Earnings Surprise Streak Alive?
- Enact Holdings (ACT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 07/10/2024
|
Enact to Host Second Quarter 2024 Earnings Call August 1st
- RALEIGH, N.C., July 09, 2024 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) announced it will issue its second quarter earnings release after the market closes on July 31, 2024. Enact will host a conference call to review second quarter 2024 financial results on August 1, 2024 at 8:00 a.m. (ET).
- 07/09/2024
|
Enact Completes XOL Reinsurance Transaction as Part of its Diversified Credit Risk Transfer Program
- Secures approximately $90 million of excess of loss reinsurance coverage from panel of reinsurers Secures approximately $90 million of excess of loss reinsurance coverage from panel of reinsurers
- 06/27/2024
|
MTG or ACT: Which Multiline Insurance Stock is Better-Positioned?
- Let's see how MGIC Investment (MTG) and Enact Holdings (ACT) fare in terms of some of the key metrics.
- 06/19/2024
|
5 Stocks With Recent Dividend Hikes to Watch
- Five stocks with recent dividend hike are: ACT, SEIC, NTAP, RY, DCI.
- 06/07/2024
|
Enact to Participate at the 2024 TD Financial Services and Fintech Summit
- RALEIGH, N.C., June 04, 2024 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) today announced that the company's President and Chief Executive Officer, Rohit Gupta, will participate in a fireside chat at the 2024 TD Financial Services and Fintech Summit on Thursday, June 6, 2024 at 4:15 pm Eastern Time.
- 06/04/2024
|
Enact Holdings, Inc. Prices $750 Million of Senior Notes
- RALEIGH, N.C., May 22, 2024 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact), today announced that it has priced a registered public offering of $750 million of its 6.25% Senior Notes due 2029 (the “2029 Notes”). The expected settlement date for the offering is May 28, 2024, subject to the satisfaction of customary closing conditions.
- 05/22/2024
|
ConMet Unveils Latest Freight Efficiency Technologies at ACT Expo 2024
- LAS VEGAS, NV / ACCESSWIRE / May 20, 2024 / ConMet, a leader in sustainable solutions for the transportation industry, is proud to showcase its latest freight efficiency technologies at ACT Expo 2024. From May 20-23, attendees can visit ConMet's booth, number 1220, at the Las Vegas Convention Center to explore these cutting-edge advancements. ConMet booth at ACT Expo 2024Among the impressive technologies on display are the Nmotion™ in-wheel power generators, TruckWings® active aerodynamics, PreSet Plus® wheel ends, interior and exterior plastic systems, and lightweight cast components. These technologies highlight ConMet's commitment to revolutionizing the freight industry by increasing efficiency and reducing environmental impact.The Nmotion TR series of power generators for refrigerated trailers is a game-changer for improving freight efficiency in commercial vehicles. Utilizing in-wheel electric motors, this technology generates power that can be used to operate an electric transport refrigeration unit (eTRU). As a result, refrigerated trailers can achieve zero emissions, eliminating fuel costs and CO2 output. A complete Nmotion system will be on display at ACT Expo on a Carrier Transicold Vector eCool trailer.TruckWings technology, another standout product on display, enhances freight efficiency by automatically closing the gap between the tractor and trailer at highway speeds. This innovative solution improves aerodynamics, resulting in an average 3-6% increase in vehicle efficiency, no matter the fuel source. With TruckWings, ConMet empowers fleets to achieve significant fuel savings and reduce their carbon footprint or extend the mileage range on EV trucks.A Freightliner eCascadia, provided by Knight-Swift Transportation, will be on display in the ConMet booth during ACT Expo showcasing the TruckWings product on an electric truck. ACT Expo attendees are invited to stop by and see the device in action.In addition to these groundbreaking advancements, ConMet's PreSet Plus wheel ends offer a range of benefits for the freight industry. Constructed with lightweight aluminum, these wheel ends reduce the overall weight of the vehicle, leading to increased fuel efficiency. ConMet is also taking the next step in wheel end technology, with reengineered seals and bearings to further reduce rolling resistance, enhancing vehicle efficiency even more.ConMet's commitment to sustainability is further exemplified by the use of interior and exterior plastic systems, which can replace metal components in some cases for weight reduction. Non-structural plastic parts can also be made with sustainable fillers for additional carbon offset in production.Visit booth 1220 at the Las Vegas Convention Center from May 20-23 to discover how ConMet is revolutionizing freight efficiency through its commitment to providing transformative and sustainable solutions to the commercial vehicle industry.About ConMet ConMet, a division of Amsted Industries, is a leading global provider to original equipment manufacturers and aftermarket channels in the commercial vehicle industry. From wheel ends, cast metal components, and plastic systems to zero-emission technologies, automated aerodynamic devices, and IoT solutions, ConMet helps move the industry forward. Today, ConMet products are standard equipment on most heavy-duty vehicles in North America and have a growing footprint worldwide. Contact InformationDavid Brierley Media Relations Manager marketing@conmet.com 360 409 6570 SOURCE: ConMetView the original press release on newswire.com.
- 05/20/2024
|
WiTricity, International Transportation Service Launch Pilot Wireless Charging on Ford E-Transit Fleet at Port of Long Beach
- WATERTOWN, Mass. and LONG BEACH, Calif., May 20, 2024 /PRNewswire/ -- WiTricity, the leader in wireless electric vehicle charging, and International Transportation Service LLC (ITS) are launching a first-of-its-kind pilot program at the Port of Long Beach. The six-month program will test the effectiveness and efficiency of WiTricity's patented wireless charging technology in real-world conditions. This initiative will allow ITS to assess the effect of wireless charging on operational costs as it electrifies its light-duty fleet. It also highlights two significant firsts: the first wirelessly charged Ford E-Transit using WiTricity technology, and the first collaboration between WiTricity and ITS showcasing WiTricity's Halo™ wireless EV charging system in a practical fleet setting. WiTricity's wireless chargers will power a portion of ITS's light-duty fleet, which is used for transporting staff and visitors around the busy terminal. The data collected will guide ITS as it moves forward with plans to fully electrify its light-duty fleet. WiTricity's technology allows EVs to be charged simply by parking over a charging pad, offering the same speed and efficiency as a standard Level 2 plug but with enhanced convenience, reliability, and safety. WiTricity will be featuring the Ford E-Transit with wireless charging capability at the ACT show in booth #1200, providing an opportunity for industry professionals to see the technology firsthand. "The International Transportation Service pilot program will yield meaningful real-world data on the benefits of our wireless charging for fleets," said Joe Benz, CEO of WiTricity. "Our WiTricity Halo™ wireless EV charging platform unlocks significant potential for commercial deployments, offering seamless, efficient charging that improves safety, reduces costs, and optimizes workflow. This pilot program is a great first step to help ITS minimize the total cost of ownership of electrifying its fleet." "The San Pedro gateway has seen dramatic changes in the container market, customer behavior, modal shifts, and regulatory environment over the last few years," said ITS CEO Kim Holtermand. "Throughout these changes, ITS has continuously invested in equipment, systems, and people to offer agile, solution-focused, and greener services to our customers across the supply chain." WiTricity is the pioneer in wireless charging for electric vehicles, leading the development and implementation of magnetic resonance technology across both passenger and commercial vehicles. The company's extensive patent portfolio is critical to the global EV wireless charging standards ratified by SAE, ISO, and GB. WiTricity's technology is indispensable for the wireless charging of various products, from consumer electronics to micro-mobility and robotics. International Transportation Service (ITS) has been a leader in reducing air pollution associated with port-related operations since 2006. Even before the San Pedro Bay ports adopted their original Clean Air Action Plan, ITS was the first container terminal operator to sign a full 20-year green lease with the Port of Long Beach, leading the way for ships calling at the Port of Long Beach to run on electricity at berth, using renewable fuels to power container yard equipment, and accelerating turnover of cargo handling equipment to the cleanest available technologies. ITS' commitment to greening its operations now extends to investment in the latest hybrid drive technology to power its rubber-tired gantry cranes and most recently the extension of its light-duty fleet to include the Ford E-Transit.
- 05/20/2024
|
BAE Systems and Eaton successfully test electric drive technology on commercial demonstration truck
- ENDICOTT, N.Y.--(BUSINESS WIRE)--BAE Systems, a leader in electric propulsion, and Eaton, a global power management company, successfully tested their integrated electric drive system for medium- and heavy-duty commercial trucks. Using this technology, existing truck models can be easily adapted across various zero-emission applications, improving efficiency, performance, and flexibility. Testing occurred at Eaton’s proving grounds in Marshall, Michigan on a Class 7 demonstration vehicle. The vehicle met key on-road performance goals, including gradeability and highway speed, all within a single electric vehicle (EV) system. The compact system helps increase electrical efficiency and reduce vehicle weight. “Our robust solution is built on proven technology to meet the unique demands of EV trucks,” said Bob Lamanna, vice president and general manager of Power & Propulsion Solutions at BAE Systems. “This integrated approach simplifies the complex electric drive system for trucks and commercial vehicles.” BAE Systems’ electric motor and suite of modular power electronics is combined with Eaton’s MD 4-speed EV transmission to create a comprehensive system for commercial vehicles. It can also be fitted with Eaton’s HD-4 EV transmission, offering a full line of electric drive systems for commercial trucks above 19 tons. The BAE Systems and Eaton system gives original equipment manufacturers a durable and optimized electric drive solution for a wide range of platforms. Due to unique architecture, it uses a reduced number of components, cables, and connections, saving space and weight on the vehicle. The complete system simplifies the integration process, improves reliability, increases value, and lowers overall cost. BAE Systems’ electric drive technology builds on more than 25 years of innovation that powers low- and zero-emission platforms on land and sea, including battery electric, fuel cell, and hybrid electric vehicles. The company has more than 17,000 propulsion systems operating in transit buses, boats, military, and industrial vehicles across the globe with over five billion miles of proven performance. The BAE Systems demonstration truck will be on display at the 2024 ACT Expo. BAE Systems’ electric propulsion technology is developed, manufactured, and serviced at its facilities in Endicott, New York, Rochester, UK, and Guaymas, Mexico.
- 05/20/2024
|
Blue Bird Debuts Electric Step Van at 2024 Advanced Clean Transportation (ACT) Expo
- MACON, Ga.--(BUSINESS WIRE)--Blue Bird Corporation (Nasdaq: BLBD), the leader in electric and low-emission school buses, will debut its electric-powered step van at the upcoming 2024 Advanced Clean Transportation (ACT) Expo, North America's largest advanced transportation technology and clean fleet event. The company teamed up with Xos (Nasdaq: XOS) and Morgan Olson to manufacture the prototype. Blue Bird will showcase its groundbreaking zero-emission vehicle and underlying stripped chassis at.
- 05/20/2024
|
The Best Public High School in America: The Top 50 Ranked
- Public high schools are a necessity, but the one near you may not necessarily be the best for your student. Finding the best school district near you, even if it’s a distance away, might be worth it to see your child succeed. However, if you have the money, private schools are also an option. The National Assessment of Education Progress, a U.S. Department of Education program, found that in 2019, just 37% of high school seniors were proficient in reading, and only 24% were proficient in math. Still, despite the apparent deficiencies of the education system at large, many public schools across the country have distinguished themselves through exceptional student outcomes. Using data compiled by Niche, an education and community research platform, 24/7 Wall St. identified the 50 best public high schools in America for 2024. Niche ranked schools based on a weighted index of multiple measures, including standardized test results, graduation rates, AP enrollment, student-teacher ratios, and parent and student surveys. A full description of each measure and its weighting is available here. Charter and magnet schools were excluded from the analysis. As you might notice from the list below, some states are known for having more of the best and worst schools. Among the 50 top-ranking public high schools in the United States, graduation rates range from 93% to 100%. Additionally, in each school on this list with available standardized test data, average ACT and SAT scores exceed the national averages of 20.3 out of 36 and 1050 out of 1600, respectively. Part of this could be due to some amazing teachers, while others might have exceptional funding or great programs. (Here is a look at the best places for teachers in America.) Why We Are Writing About Schools Education plays a large role in how the country works, including how people get more money, and the efficiency of businesses and corporations. For those looking to have their kids do well as they grow up, it’s important to make sure your kid has a fighting chance. These top 50 high schools give kids the education and resources they need to get into great colleges, and later get a high-paying job and life-long career. Here are the 50 best public high schools in America: 50. Radnor Senior High School Location: Radnor, PA Percent of students who graduate on average: 98% Radnor Senior High School has 1,165 students and a ratio of 13 students for every teacher. 83 percent of the students here are in AP courses. The average SAT score is 1350 and the average ACT score is 31. 49. Weston High School Location: Weston, MA Avg. graduation rate: 95% Weston High School has only 638 students, and 11 students for every teacher. Roughly 61.9 percent of students are in an AP course. The average SAT score is 1340 while the average ACT score is 31. 48. Winston Churchill High School Location: Potomac, MD Avg. graduation rate: 96% Winston Churchhill High School has 2,212 students and enough teachers for them to handle 18 students at a time. There are 73.2 students enrolled in one or more AP courses. The average SAT score is 1380 and the average ACT score is 31. 47. Jericho Senior High School Location: Jericho, NY Avg. graduation rate: 99% Jerico Senior High School has 1,205 students, making a student-teacher ratio of 12 to 1. 1420 is the average SAT score and 31 is the average ACT score. 58.3 students are in AP courses. 46. Great Neck South High School Location: Great Neck, NY Avg. graduation rate: 97% Great Neck South High School has 1,222 students, about 46 percent of whom are in an AP course. There are 11 students for every teacher. 1400 is the average SAT score and 31 is the average ACT score for kids enrolled here. 45. Conestoga Senior High School Location: Berwyn, PA Avg. graduation rate: 98% Conestoga High School has 2,355 students and a teacher to handle every 16 students on average. The average SAT score is 1360 and the average ACT score is 30. There are roughly 51 students enrolled in an AP course. 44. Hinsdale Central High School Location: Hinsdale, IL Avg. graduation rate: 94% This high school had 2,544 students, with one teacher for every 13 or so kids. 40.4 percent of children enrolled are in at least one AP course. 1360 and 31 are the average SAT and ACT scores respectively. 43. University High School Location: Irvine, CA Avg. graduation rate: 94% University High School has 2,097 students and 25 students for every teacher. 44.5 percent of students are enrolled in AP courses. The average SAT score is 1400 and the average ACT score is 31. 42. Palo Alto High School Location: Palo Alto, CA Avg. graduation rate: 97% Palo Alto High School usually has around 2,010 students enrolled and a student-teacher ratio of around 17 to 1. Though less than half, 42.5 percent, of students are in an AP course, the average SAT score is 1400 and the average ACT score is 31. 41. Walt Whitman High School Location: Bethesda, MD Avg. graduation rate: 96% Walt Whitman High school has 18 students for every teacher for a total of 2,029 students. 65 percent are enrolled in AP courses. The average SAT score is 1380 while the average ACT score is 31. 40. Lexington High School Location: Lexington, MA Avg. graduation rate: 99% Lexington High School has plenty of teachers for the average 2,273 students with a ratio of 12 students for every teacher. 44.6 percent of students are in AP courses. 1390 and 32 are the average scores for the SAT and ACT respectively. 39. Westwood High IB World School Location: Austin, TX Avg. graduation rate: 98% With 2,781 students, this Austin school has a student-teacher ratio of 16 to 1. 49.6 students are in at least one AP course. The average ACT score is 31 and the average SAT score is 1360. 38. Glenbrook North High School Location: Northbrook, IL Avg. graduation rate: 98% The student-teacher ratio is 13 to 1 at this school, with 2,052 students enrolled. 31 percent are in at least one AP course. The average SAT and ACT scores are 1340 and 3 respectively. 37. High School Math Science & Engineering at The City College of New York (CCNY) Location: New York, NY Avg. graduation rate: 95% This New York school has about 524 students for a ratio of 16 students to every teacher. The average scores for the SAT and the ACT are 1420 and 31 respectively. 96 percent of students are in AP classes. 36. River Hill High School Location: Clarksville, MD Avg. graduation rate: 99% River Hill High School has 1,508 students or so, for an average of 18 students to 1 teacher. About 62 percent of students there are enrolled in AP courses. 31 is the average ACT score while 1370 is the average SAT score. 35. Glenbrook South High School Location: Glenview, IL Avg. graduation rate: 98% This Glenview High School has 3,080 students, and a ratio of 14 students for ever teacher. About 31 students are in an AP course. The SAT scores average out to 1310 while the ACT score averages out to 30. 34. Neuqua Valley High School Location: Naperville, IL Avg. graduation rate: 98% This high school has 3,297 students in its halls, for an average of 15 students to 1 teacher. 44.4 percent of students are in an AP course. 1330 is the average SAT score while 29 is the average ACT. 33. New Trier Township High School Location: Winnetka, IL Avg. graduation rate: 98% New Trier Township High School has just under 3,000 students with 1 teacher for every 12 students. The average ACT score is 30 and the average SAT score is 1350. There are about 29 students in an AP course here. 32. The College Academy at Broward College Location: Davie, FL Avg. graduation rate: 100% The College Academy in Davie, Florida has a ratio of 27 to 1 students to teachers, with about 466 students. Every student is known to graduate and come out with an average SAT score of 1300 and an ACT score of 28. 31. Bergen County Technical High School – Teterboro Location: Teterboro, NJ Avg. graduation rate: 95% This Teterboro technical high school has about 678 students and a ratio of 1 teacher for every 10 students. 66 percent of the students are in AP courses and the SAT score averages out to 1390 while the ACT score is about 32. 30. Aspire, Deer Valley’s Online Academy Location: Phoenix, AZ Avg. graduation rate: 94% This online academy has 370 students enrolled at one time on average, and a student-teacher ratio of 11 to 1. Since it’s just an online school, SAT and ACT scores are not necessarily connected to information about the school as students have to register for those separately. 29. West Lafayette Junior/Senior High School Location: West Lafayette, IN Avg. graduation rate: 95% West Lafayette’s high school has 1,100 students enrolled and a 13 to 1 ratio of students to teachers. There are only about 35 percent of students enrolled in an AP course, but the average SAT score is 1350, and the average ACT score is 32. 28. Carroll Senior High School Location: Southlake, TX Avg. graduation rate: 99% Carroll Senior High School has 1,394 students on average, which makes for a student-teacher ratio of 14 to 1. About 62 percent of students are in an AP course. The average ACT score is 30 and the average SAT score is 1350. 27. Ladue Horton Watkins High School Location: St Louis, MO Avg. graduation rate: 97% This high school has 14 students to 1 teacher on average and 1,324 students. Just under half, 48.6 percent, of students are in AP classes. 1450 is the rather impressive average SAT score while 29 is the average ACT score. 26. Bard High School Early College Queens Location: Long Island City, NY Avg. graduation rate: 95% 675 is the average number of students, with a ratio of 12 students to one teacher. The testing scores are 1360 and 30 for the SAT and ACT respectively. 25. Half Hollow Hills High School West Location: Dix Hills, NY Avg. graduation rate: 93% Even with 1,035 students, the student-teacher ratio is nine to one. 85.5 percent of students are in AP courses. The average SAT score is 1290 and the average ACT score is 29. 24. Academy of the Canyons Location: Santa Clarita, CA Avg. graduation rate: 95% The student-teacher ratio for the Academy of the Canyons is 28 to 1 with just under 400 students. 1330 is the average score for the SAT while 30 is the average for the ACT. 23. Westlake High School Location: Austin, TX Avg. graduation rate: 99% Westlake High School has 2,823 students on average, with over 99 percent of them graduating. The ratio is 14 to 1 students to teachers. 68.8 percent of students are in at least one AP class and the average testing scores are 1360 for the SAT and 31 for the ACT. 22. Canyon Crest Academy Location: San Diego, CA Avg. graduation rate: 99% With 2,346 students enrolled in this San Diego school, the graduation rate is 99 percent and the ratio of students to teachers is 28 to 1. The SAT score averages out to 1420 while the ACT score is about 32. 56.7 percent of students are in an AP course. 21. School for Advanced Studies – Wolfson Location: Miami, FL Avg. graduation rate: 95% Wolfson offers a student-teacher ratio of 41 to 1 with around 123 students. Almost every child is in an AP course. 1330 and 29 are the respective average scores for the SATs and the ACTs. 20. University High School Location: Tucson, AZ Avg. graduation rate: 99% This school has a high ratio of students to teachers, about 23 to 1. There are 1,129 students with a 99 percent graduation rate and 100 percent of students in an AP course. 1340 and 30 are the respective average scores for the SAT and ACT. 19. Henry M. Gunn High School Location: Palo Alto, CA Avg. graduation rate: 96% With 1,868 students, the ratio of students to teachers is 17 to 1. About 40 percent of students are enrolled in AP courses. Meanwhile, 1430 and 32 are the respective averages for the SAT and the ACT. 18. Arkansas School for Mathematics, Sciences, and the Arts Location: Hot Springs, AR Avg. graduation rate: 100% 255 students make the student-teacher ratio at this Arkansas school eight to one. 30 is the average ACT score while 1390 is the average for the SAT. 17. High School of American Studies at Lehman College Location: Bronx, NY Avg. graduation rate: 95% The student-teacher ratio in Lehman College is 144 to 1 with 408 students. About 70 percent are enrolled in an AP course. 33 is the average ACT score and 1430 is the average score for the SAT. 16. School for Advanced Studies – Homestead Location: Homestead, FL Avg. graduation rate: 95% There are almost no students in this Homestead school, only about 133. The student-teacher ratio is 33 to 1. However, pretty much every child is enrolled in an AP course. The average SAT and ACT scores are 1300 and 28 respectively. 15. Scarsdale Senior High School Location: Scarsdale, NY Avg. graduation rate: 99% The student-teacher ratio in Scarsdale is 11 to 1 with 1,471 students or so. Almost every student graduates and passes the SAT and ACT with flying colors with the average scores being 1420 and 32 respectively. 14. Biotechnology High School Location: Freehold, NJ Avg. graduation rate: 95% With 315 students, the student-teacher ratio is 12 to 1. Not many students are in AP classes, with only about 22.6 percent of the students taking one. However, they’re great at taking the ACT with an average score of 34. The SAT score average is also pretty good at 1490. 13. Marine Academy of Technology & Environmental Science Location: Manahawkin, NJ Avg. graduation rate: 95% This school has 274 students for a student-teacher ratio of 12 to 1. Their SAT scores are usually around 1430 while their ACT scores are around 33. 12. Troy High School Location: Fullerton, CA Avg. graduation rate: 99% Troy High School in California has about 2,614 students and a student-teacher ratio of 23 to 1. About 67 percent of students take AP classes. The average SAT score is 1400 and the average ACT score is 32. 11. A.D. Henderson University School & FAU High School Location: Boca Raton, FL Avg. graduation rate: 100% With about 1,300 students, the student-teacher ratio is at a very high 30 to 1 at this high school. However, with a graduation rate of 100 percent, ACT scores averaging 31, and SAT scores near 1370, this school isn’t suffering for its lack of teachers. 10. Adlai E. Stevenson High School Location: Lincolnshire, IL Avg. graduation rate: 97% This high school has 4,392 students, half of which are enrolled in an AP course. The student-teacher ratio is 16 to 1. The average SAT score is 1360 and the average ACT is 31. 9. High Technology High School Location: Lincroft, NJ Avg. graduation rate: 95% There aren’t many teachers at the High Technology High School. Though the ratio is 13 to 1, there are under 300 students on average. 43.6 percent of the students are enrolled in an AP course. Where these students do best though is during testing. The average ACT score is 33 while the average SAT score is 1530. 8. Stuyvesant High School Location: New York, NY Avg. graduation rate: 99% Stuyvesant has a pretty high student-teacher ratio of 21 to 1 with 3,300 students enrolled on average. Also, only 55 percent of students are enrolled in an AP course. However, that hasn’t stopped these kids from excelling with an average graduation rate of 99 percent, 1500 as the average SAT score, and 33 as the average ACT score. 7. Gwinnett School of Mathematics, Science & Technology Location: Lawrenceville, GA Avg. graduation rate: 99% Gwinnett has a student-teacher ratio of 16 to 1, with 1,165 students. Only 72 percent of students are enrolled in an AP course. The average SAT score is 1390 and the ACT score is 31. 6. Townsend Harris High School Location: Flushing, NY Avg. graduation rate: 99% This high school in Flushing has a student-teacher ratio of 16 to 1 with about 1,347 students. The average ACT score is 32 and the average SAT score is 1420. Roughly 90 percent of students are in an AP course. 5. Bronx High School of Science Location: Bronx, NY Avg. graduation rate: 99% The Bronx High School of Science has a student-teacher ratio of 21 to one, with about 3,000 students. Only about 68 percent of students are enrolled in AP courses. The SAT scores average out to 1450, while the ACT scores are about 33. 4. Staten Island Technical High School Location: Staten Island, NY Avg. graduation rate: 99% Staten Island Technical High School has an average graduation rate of 99 percent. There are around 1,355 students enrolled for a rather high ratio of 19 students to 1 teacher. However, this hasn’t affected the children much with over 95 percent of students in an AP course. Additionally, 1440 is the average SAT score and 33 is the average ACT score. 3. South Carolina Governor’s School for Science & Mathematics Location: Hartsville, SC Avg. graduation rate: 95% This South Carolina School enrolls about 300 students at a time, most of which are in AP courses. The average SAT score is 1380 and the ACT score is 31. About 95 percent of students graduate. 2. Oklahoma School of Science and Mathematics Location: Oklahoma City, OK Avg. graduation rate: 100% Oklahoma’s School of Science and Mathematics has a very low enrollment, around 120 students. Because of this, it’s able to keep a student-teacher ratio of about four to one. Pretty much every student graduates. The average SAT score is 1420 and the ACT score is 32. 1. North Carolina School of Science and Mathematics Location: Durham, NC Avg. graduation rate: 99% The North Carolina School of Science and Music is the number one school in the United States. It has an average SAT score of 1450 and an ACT score of 33. There are usually close to 1,000 students enrolled, with a student-teacher ratio of eight to one. Buffett Missed These Two… Warren Buffett loves dividend stocks, and has stuffed Berkshire with some of his favorites. But he overlooked two dividend legends that continue to print checks on a new level, they’re nowhere in his portfolio. Unlock the two dividend legends Buffett missed in this new free report. The post The Best Public High School in America: The Top 50 Ranked appeared first on 24/7 Wall St..
- 05/20/2024
|
Achates’ demonstrates up to 20% efficiency improvement v. today’s engines while meeting 2027 ultra-low NOx standards with today’s aftertreatment
- LAS VEGAS--(BUSINESS WIRE)--Achates Power, Inc. (API) showcased at ACT Expo what has been demonstrated as the cleanest and most efficient internal combustion engine (ICE) architecture to date. Demonstrations have proven ability to satisfy regulatory requirements without detriment to the fleets or economy. “In pursuit of clean technology, it’s critical to place priority on the fleets and drivers. Technology-forcing regulations with uncertainty on infrastructure, cost, and capability to ‘do the job’ make it difficult to navigate this energy transition,” said Dave Crompton, CEO of API. “For the first time, an ICE architecture has been simultaneously proven to reduce NOx, beat the most stringent regulations proposed with margin to spare, and improve real world fuel economy by as much as 20%, while demonstrating extended life compliance.” API demonstrated the opposed-piston (OP) architecture is capable of using today’s aftertreatment systems to meet tomorrow’s ultra-low NOx emissions standards with robust compliance through the 800,000 mile useful life requirements. Low-load, idle, and off-cycle emissions capability positions this to be the best combustion technology in the industry. Stringent emissions regulations in commercial trucking are to a point where aftertreatment systems’ cost and complexity may drive truck costs higher, reliability lower, and penalize fuel economy. In a joint demonstration with CALSTART and Walmart, an API 10.6 liter engine was retrofitted into a production class 8 truck to meet the proposed 2027 ultra-low NOx emissions standard and with an off-the-shelf current production one-box aftertreatment system. Testing in California achieved up to 10.8 mpg on a 389 mile delivery route averaging 10% better fuel economy than baseline with the advantage increasing to 22% on some routes. In February at Argonne National Laboratory, the Department of Energy began testing an API engine utilizing hydrogen combustion with compression ignition. The simplicity of this design enables an easier transition to hydrogen combustion over 4-stroke concepts. In joint testing with renewable diesel producer Neste, the already proven 10% greenhouse gas emissions (GHG) reduction of the OP engine was amplified when using R99. Testing resulted in 4-5% GHG emissions reduction compared to fossil diesel across all test cycles - the lowest GHG level API measured to-date. Benefits of the API engines include lower heat rejection, higher power density, and fewer moving parts for better reliability and increased fuel efficiency. Every stroke is a power stroke, providing optimal thermal efficiency. This matters to fleets for 2027 and beyond emissions regulations where thermal management impacts aftertreatment cost, simplicity and functionality. API technology is obtainable without the use of exotic materials, non-conventional manufacturing, or complex aftertreatment systems - making it a ‘now’ solution for the fleets. “API has demonstrated that its technology can be put into practical use without the added complexity, cost and reliability concerns associated with stretching conventional engines and emission systems to meet the future low NOx and CO2 limits, and without the need for a fleet to redesign routes around shorter-range vehicles and sparse refueling/recharging infrastructure,” said Dr. John Wall, Board of Directors, API and former Cummins CTO. “For fleets that ultimately want to reach zero-net-carbon emissions, including renewable diesel and hydrogen, the Achates technology is a good match." This architecture can be manufactured through sustainable assembly practices and with approximately 300 fewer parts compared to today’s 4-stroke engines. Materials can be procured through today’s supply chain efficiently supporting the manufacturing of this engine architecture without sourcing disruptions and constraints. Click Here for full press release.
- 05/20/2024
|
Range Energy Announces the Development of a Trailer Data and Telematics Platform to Enhance Operational Efficiency for Fleets
- MOUNTAIN VIEW, Calif. & LAS VEGAS--(BUSINESS WIRE)--Range Energy (Range), the company bringing powered trailers to the commercial trucking market, today at the Advanced Clean Transportation (ACT) Expo unveiled the development of a new trailer data and telematics platform that will bring unique operational insights to its electric-powered trailer customers. The platform is being developed in partnership with connected vehicle technology company, Sibros, and is built upon the company’s Deep Connected Platform (DCP), which is purpose-built to provide original equipment manufacturers (OEMs) with a leading-class, implementation-ready connected vehicle solution for data logging, software updates, and remote commands. Range is in the development phase of its next-generation powered trailer hardware platform, which includes expanding its technology stack with software elements that lead to greater fleet efficiency and operational savings. This new trailer and data telematics platform is pivotal to Range’s adoption as it allows fleets to gain critical insight into emissions savings for reporting, as well as analysis around trailer utilization, predictive maintenance, route efficiency, and more. “Our electric-powered trailers are critical for commercial fleets to quickly decarbonize, enhance safety, and improve vehicle efficiency. Our new data and telematics platform serves that need by providing unparalleled insights that help fleets monitor and optimize their operations,” said Ali Javidan, CEO and founder, Range. “Our collaboration with Sibros is key to ensuring our customers gain the most value from adopting our electric trailers. In addition, this partnership builds upon our technology stack and underscores our commitment to continue innovating and improving our products.” Recently, Range has achieved a number of key commercial, regulatory, and technical milestones. These include an agreement with Thermo King to integrate its electric-powered trailer platform with Thermo King’s trailer refrigeration units, announcing a pilot with DB Schenker, securing $23.5 million in new financing, launching a Dealer Advisory Council to support commercialization, and becoming the first trailer electrification platform to be eligible for California’s Clean Off-Road Equipment (CORE) Voucher Project. Range also announced a full certified fuel economy test report by Mesilla Valley Transportation Solutions (MVTS), which highlighted 36.9 percent fuel efficiency improvements (+3.25 MPG) achieved with Range’s electric-powered trailer, among other notable improvements. “At Sibros, we pride ourselves on the robust deployment of our solutions across diverse fleets, including passenger vehicles, heavy-duty trucks, motorcycles, and more. This is the first trailer application for us, and we’re excited to help the Range team bring a compelling data platform to market, paving the way for enhanced product utility and customer satisfaction,” said Mayank Sikaria, president and co-founder, Sibros. “Together with Range, we are setting a new industry standard for trailer applications and helping drive a transformative era in vehicle data analytics and connectivity,” added Sikaria. During the ACT Expo, Range will be providing a simulated experience of the trailer data and telematics platform at Booth 931. Reach out to sales@range.energy to book a demo. About Range Energy Range Energy (Range) accelerates the electrification of commercial transportation via powered trailers for the heavy duty truck market. With a solution that can easily hook up to any tow vehicle, Range’s powered trailers offer offroad mobile power, and can rapidly ease the transition to electrification and meet its commercial partners' immediate needs and long-term ambitions. Range was founded in 2021 and is led by a team with deep EV industry expertise from Tesla, Zoox, Honda, and more. The company is backed by leading investors including Trousdale Ventures, UP Partners, R7, Yamaha Motor Ventures, and more.
- 05/20/2024
|
Ballard launches 9th generation high-performance fuel cell engine for heavy-duty vehicles at ACT Expo 2024
- VANCOUVER, BC and LAS VEGAS , May 20, 2024 /PRNewswire/ - Ballard Power Systems (NASDAQ: BLDP) (TSX: BLDP) today unveils its 9th generation, high-performance fuel cell engine, the FCmove®-XD, at the Advanced Clean Transportation (ACT) Expo at the Las Vegas Convention Center. Ballard is exhibiting at Booth 1821 from May 20-23, 2024.
- 05/20/2024
|
Eaton Introduces Higher Power Fuses for Electrified Commercial Vehicles
- SOUTHFIELD, Mich.--(BUSINESS WIRE)--Intelligent power management company Eaton today announced it is now offering a portfolio of fuses for commercial electrified vehicles (EVs). Eaton Bussmann series fuses can handle up to 1,400 amps and 900 volts and can be tailored to customer specifications. Eaton can increase current capability by either design modifications or paralleling multiple fuses. The fuses will be on display in Eaton’s booth at the largest advanced commercial vehicle technology show, ACT Expo, held May 20-23 in Las Vegas, Nevada. “We have adapted our fuses to be the ideal solution for electrified commercial vehicles, which require greater power than passenger EVs,” said Kimberley Wakelin, engineering manager, protection EV, Eaton. “Electrified vehicles are propelled by electric motors, which are cyclic and need to perform in harsh environments. This means the fuses must be able to handle such conditions and the vehicle's vibrations. Our innovative Bussmann series fuses solve that challenge, keeping up with harshness and vibration levels.” Eaton has a unique position in the market, with more than 100 years of experience in the electrical and vehicle industries. Eaton leveraged its strong grasp of vehicle systems and dynamics and its expertise in electrical systems to develop fuses that can be adapted to customer specifications in the growing electrified commercial vehicle space. Eaton’s vast global testing capabilities give it the ability to conduct most tests in-house rather than having to outsource testing. “We have the capability to do even the most difficult testing, including environmental, thermal shock chamber and vibration rig tests,” Wakelin said. Eaton partners early in the vehicle development process with global OEMs to develop custom fuse solutions for electrified commercial vehicles. Once developed, Eaton simulates the system to ensure its longevity. As recently announced, Eaton is expanding manufacturing capacity of its fuses with the opening of a new, state-of-the-art assembly plant. Learn more about Eaton’s line of electrified commercial vehicle fuses. Eaton is an intelligent power management company dedicated to protecting the environment and improving the quality of life for people everywhere. We make products for the data center, utility, industrial, commercial, machine building, residential, aerospace and mobility markets. We are guided by our commitment to do business right, to operate sustainably and to help our customers manage power ─ today and well into the future. By capitalizing on the global growth trends of electrification and digitalization, we’re accelerating the planet’s transition to renewable energy sources, helping to solve the world’s most urgent power management challenges, and building a more sustainable society for people today and generations to come. Eaton was founded in 1911 and has been listed on the New York Stock Exchange for more than a century. We reported revenues of $23.2 billion in 2023 and serve customers in more than 160 countries. For more information, visit http://www.eaton.com. Follow us on LinkedIn.
- 05/20/2024
|
Enact Holdings, Inc. (ACT) Q1 2024 Earnings Call Transcript
- Enact Holdings, Inc. (NASDAQ:ACT ) Q1 2024 Earnings Conference Call May 2, 2024 8:00 AM ET Corporate Participants Daniel Kohl - VP, Investor Relations Rohit Gupta - President and Chief Executive Officer Dean Mitchell - Chief Financial Officer Conference Call Participants Doug Harter - UBS Mihir Bhatia - Bank of America Bose George - KBW Rick Shane - JPMorgan Soham Bhonsle - BTIG Operator Good day and thank you for standing by. Welcome to Enact's First Quarter 2024 Earnings Call.
- 05/04/2024
|
Enact Holdings, Inc. (ACT) Beats Q1 Earnings Estimates
- Enact Holdings, Inc. (ACT) came out with quarterly earnings of $1.04 per share, beating the Zacks Consensus Estimate of $0.99 per share. This compares to earnings of $1.08 per share a year ago.
- 05/01/2024
|
Enact Reports First Quarter 2024 Results
- GAAP Net Income of $161 million, or $1.01 per diluted share Adjusted Operating Income of $166 million, or $1.04 per diluted share Return on Equity of 13.8% and Adjusted Operating Return on Equity of 14.2% Record Primary insurance in-force of $264 billion, a 4% increase from first quarter 2023 PMIERs Sufficiency of 163% or $1,883 million Book Value Per Share of $29.89 and Book Value Per Share excluding AOCI of $31.40
- 05/01/2024
|
Enact Announces 16% Increase to Quarterly Dividend and New $250 Million Share Repurchase Program
- RALEIGH, N.C., May 01, 2024 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) a leading provider of private mortgage insurance through its insurance subsidiaries, today announced that its Board of Directors declared a quarterly dividend of $0.185 per common share, an increase of 16% from the prior quarter's dividend. This dividend will be payable on June 13, 2024, to shareholders of record on May 29, 2024. Future dividends will be subject to Board approval.
- 05/01/2024
|
Why Earnings Season Could Be Great for Enact Holdings (ACT)
- Enact Holdings (ACT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 04/30/2024
|
ROOT to Come Up With Q1 Earnings: Here's What to Expect
- The first-quarter performance of ROOT, an auto insurer with a focus on the personal line, is likely to have benefited from better pricing and underwriting technology as well as prudent cost management.
- 04/29/2024
|
Can AIG Navigate Through Lower Premiums in Q1 Earnings?
- AIG's first-quarter results are likely to reflect a decline in premiums and growth in net investment income.
- 04/29/2024
|
Enact Holdings, Inc. (ACT) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
- Enact Holdings (ACT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/24/2024
|
High Temperature Superconductors, Inc. Powers Up: $5M ARPA-E Program Work Begins
- SANTA BARBARA, Calif.--(BUSINESS WIRE)--High Temperature Superconductors, Inc., (HTSI) starts novel manufacturing project for HTS superconducting tape with ARPA-E funding, DOE support.
- 04/23/2024
|
Aduro Clean Technologies to Present at European Recycling
- LONDON, Ontario, April 11, 2024 (GLOBE NEWSWIRE) — Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (CSE: ACT) (OTCQX: ACTHF) (FSE: 9D50), a Canadian technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, is pleased to announce its … The post Aduro Clean Technologies to Present at European Recycling appeared first on Headlines of Today...
- 04/11/2024
|
Will Enact Holdings (ACT) Beat Estimates Again in Its Next Earnings Report?
- Enact Holdings (ACT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 04/10/2024
|
Don't Overlook These Highly Ranked Insurance Stocks it's Time to Buy
- With a number of insurance stocks currently holding spots on the Zacks Rank #1 (Strong Buy) list, the Zacks Insurance-Multi Line Industry is standing out in particular.
- 04/04/2024
|
Enact to Host First Quarter 2024 Earnings Call May 2nd
- RALEIGH, N.C., April 04, 2024 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) announced it will issue its first quarter earnings release after the market closes on May 1, 2024. Enact will host a conference call to review first quarter 2024 financial results on May 2, 2024 at 8:00 a.m. (ET).
- 04/04/2024
|
Enact Integrated with PMI Rate Pro for Seamless Ordering
- RALEIGH, N.C., April 03, 2024 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact), a leading provider of private mortgage insurance through its insurance subsidiaries, today announced that it has completed an integration with PMI Rate Pro that enables lenders to order delegated mortgage insurance directly through their API platform.
- 04/03/2024
|
ACT vs. RDN: Which Stock Is the Better Value Option?
- Investors interested in Insurance - Multi line stocks are likely familiar with Enact Holdings, Inc. (ACT) and Radian (RDN). But which of these two companies is the best option for those looking for undervalued stocks?
- 04/01/2024
|
Enact Releases 2023 Environmental, Social, and Governance (ESG) Report
- RALEIGH, N.C., March 20, 2024 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) today announced the release of its 2023 Environmental, Social, and Governance (ESG) Report covering the calendar year 2023.
- 03/20/2024
|
Earnings Estimates Rising for Enact Holdings, Inc. (ACT): Will It Gain?
- Enact Holdings, Inc. (ACT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
- 03/07/2024
|
Is Enact Holdings (ACT) Stock a Solid Choice Right Now?
- Enact Holdings (ACT) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
- 03/01/2024
|
Enact Announces Quarterly Dividend
- RALEIGH, N.C., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) a leading provider of private mortgage insurance through its insurance subsidiaries, today announced that its Board of Directors declared a quarterly dividend of $0.16 per common share, payable on March 13, 2024, to shareholders of record on February 28, 2024. Future dividends will be subject to Board approval.
- 02/20/2024
|
Best Value Stocks to Buy for February 14th
- ACT, CAC and REYN made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 14, 2023.
- 02/14/2024
|
Enact Holdings, Inc. (ACT) Q4 2023 Earnings Conference Call Transcript
- Enact Holdings, Inc. (ACT) Q4 2023 Earnings Conference Call Transcript
- 02/07/2024
|
Enact Holdings, Inc. (ACT) Beats Q4 Earnings Estimates
- Enact Holdings, Inc. (ACT) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.90 per share. This compares to earnings of $0.90 per share a year ago.
- 02/06/2024
|
Enact Holdings, Inc. (ACT) Reports Next Week: What Awaits?
- Enact Holdings, Inc. (ACT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 01/30/2024
|
Enact to Host Fourth Quarter 2023 Earnings Call February 7th
- RALEIGH, N.C., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) announced it will issue its fourth quarter earnings release after the market closes on February 6, 2024. Enact will host a conference call to review fourth quarter 2023 financial results on February 7, 2024 at 8:00 a.m. (ET).
- 01/04/2024
|
Double Your Money: 3 Ignored Stocks Primed for Mega Growth in 2025
- In the stock market, certain hidden treasures often escape the spotlight and are overshadowed by industry giants. These companies harbor immense potential to become stocks to double your money.
- 12/31/2023
|
Enact Holdings: A Good Operator, But The Discount Is Gone
- Enact Holdings shareholders have seen a total return of 11.6% in the last six months, outperforming other mortgage insurers and the S&P. Industry analysts have upgraded Enact Holdings' select peers with positive outlooks for the mortgage insurance industry in 2024. Mortgage origination volumes are expected to remain low in 2024, with modest increases towards the end of the year and in 2025.
- 12/22/2023
|
3 Growth Stocks That Could Be Multibaggers in the Making
- The stock market has been on a tear in the past month, with the S&P500 up over 9%. Considering the market's annual average return to be around 10%, this is quite tremendous growth.
- 11/28/2023
|
Are Finance Stocks Lagging Enact Holdings (ACT) This Year?
- Here is how Enact Holdings, Inc. (ACT) and Invitation Home (INVH) have performed compared to their sector so far this year.
- 11/23/2023
|
New Strong Buy Stocks for November 9th
- LYV, USAP, AXTA, ACT and ALG have been added to the Zacks Rank #1 (Strong Buy) List on November 9, 2023.
- 11/09/2023
|
Enact Holdings, Inc. (ACT) Q3 2023 Earnings Conference Call Transcript
- Enact Holdings, Inc. (NASDAQ:ACT ) Q3 2023 Earnings Conference Call November 2, 2023 8:00 AM ET Company Participants Daniel Kohl - VP, IR Rohit Gupta - President and CEO Dean Mitchell - EVP and CFO Conference Call Participants Bose George - KBW Mihir Bhatia - Bank of America Merrill Lynch Richard Shane - JPMorgan Eric Hagen - BTIG Geoffrey Dunn - Dowling Partners Operator Good day, and thank you for standing by. Welcome to the Q3 2023 Enact Earnings Conference Call.
- 11/05/2023
|
Enact Holdings, Inc. (ACT) Upgraded to Strong Buy: What Does It Mean for the Stock?
- Enact Holdings, Inc. (ACT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
- 10/27/2023
|
Will Enact Holdings, Inc. (ACT) Beat Estimates Again in Its Next Earnings Report?
- Enact Holdings, Inc. (ACT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 10/19/2023
|
Are Finance Stocks Lagging Enact Holdings (ACT) This Year?
- Here is how Enact Holdings, Inc. (ACT) and Equinix (EQIX) have performed compared to their sector so far this year.
- 10/19/2023
|
Enact to Host Third Quarter 2023 Earnings Call November 2nd
- RALEIGH, N.C., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) announced it will issue its third quarter earnings release after the market closes on November 1, 2023. Enact will host a conference call to review third quarter 2023 financial results on November 2, 2023 at 8:00 a.m. (ET).
- 10/05/2023
|
Enact Holdings: Short-Term Challenges But Long-Term Value
- Enact Holdings Inc has shown steady growth in both top and bottom line, with potential for long-term growth. The company specializes in private mortgage insurance, providing support and risk mitigation in the mortgage lending sector. While there are short-term concerns about declining ROE and potential risks associated with rising interest rates, the company's strong shareholder return and discounted price make it an appealing investment.
- 09/25/2023
|
Are Finance Stocks Lagging Enact Holdings (ACT) This Year?
- Here is how Enact Holdings, Inc. (ACT) and Omega Healthcare Investors (OHI) have performed compared to their sector so far this year.
- 09/07/2023
|
Are Finance Stocks Lagging Enact Holdings (ACT) This Year?
- Here is how Enact Holdings, Inc. (ACT) and Omega Healthcare Investors (OHI) have performed compared to their sector so far this year.
- 08/22/2023
|
Why Enact Holdings, Inc. (ACT) Might be Well Poised for a Surge
- Enact Holdings, Inc. (ACT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
- 08/17/2023
|
Enact to Host Second Quarter 2023 Earnings Call August 2nd
- RALEIGH, N.C., July 06, 2023 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) announced it will issue its second quarter earnings release after the market closes on August 1, 2023. Enact will host a conference call to review second quarter 2023 financial results on August 2, 2023 at 8:00 a.m. (ET).
- 07/06/2023
|
Enact Holdings: Being Shareholder Friendly Offers Upside
- Enact Holdings is viewed as a relatively defensive position with well-managed risks and commitment to shareholder interests. Recommended as a "buy" for long-term investors. The capital allocation framework includes returning at least $250 million to shareholders this year through dividends and buybacks.
- 06/30/2023
|
Is Enact Holdings (ACT) Stock Outpacing Its Finance Peers This Year?
- Here is how Enact Holdings, Inc. (ACT) and Capital Southwest (CSWC) have performed compared to their sector so far this year.
- 06/08/2023
|
Is Enact Holdings (ACT) Outperforming Other Finance Stocks This Year?
- Here is how Enact Holdings, Inc. (ACT) and Assurant (AIZ) have performed compared to their sector so far this year.
- 05/23/2023
|
Best Value Stocks to Buy for May 10th
- ACT, RGA and CVGI made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 10, 2023.
- 05/10/2023
|
Enact Holdings, Inc. (ACT) Q1 Earnings and Revenues Top Estimates
- Enact Holdings, Inc. (ACT) came out with quarterly earnings of $1.08 per share, beating the Zacks Consensus Estimate of $0.79 per share. This compares to earnings of $1.01 per share a year ago.
- 05/03/2023
|
Enact Holdings: Undervalued With Expansion Potential
- The PMI sector has risen to prominence, solidifying the bedrock upon which mortgage lending operates in the contemporary epoch of the American housing market. Enact Holdings is a leading presence in the American private mortgage insurance (PMI) market, specializing in residential mortgage guaranty insurance for prime-based, individual underwritten loans.
- 04/10/2023
|
Enact to Host First Quarter 2023 Earnings Call May 4th
- RALEIGH, N.C., April 06, 2023 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) announced it will issue its first quarter earnings release after the market closes on May 3, 2023. Enact will host a conference call to review first quarter 2023 financial results on May 4, 2023 at 8:00 a.m. (ET).
- 04/06/2023
|
Is the Options Market Predicting a Spike in Enact Holdings (ACT) Stock?
- Investors need to pay close attention to Enact Holdings (ACT) stock based on the movements in the options market lately.
- 03/28/2023
|
Enact Holdings, Inc. (ACT) Q4 2022 Earnings Call Transcript
- Enact Holdings, Inc. (NASDAQ:ACT ) Q4 2022 Earnings Conference Call February 7, 2023 8:00 AM ET Company Participants Daniel Kohl - Vice President, Investor Relations Rohit Gupta - President & Chief Executive Officer Dean Mitchell - Chief Financial Officer & Treasurer Conference Call Participants Doug Harter - Credit Suisse Mihir Bhatia - Bank of America Bose George - KBW Eric Hagen - BTIG Operator Good day and welcome to the Q4 2022 Enact Earnings Conference Call. At this time, all participants are in a listen-only mode.
- 02/07/2023
|
Enact Holdings, Inc. (ACT) Lags Q4 Earnings and Revenue Estimates
- Enact Holdings, Inc. (ACT) delivered earnings and revenue surprises of -2.17% and 1.17%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 02/06/2023
|
Enact Holdings: Resilient Balance Sheet For A Tough Mortgage Environment
- Private mortgage insurer Enact Holdings has performed better than peers over the last 12 months in spite of common headwinds from the housing. Going into 2023 which is expected to be a slow year for new mortgages, the balance sheet appears robust, with shares at a slight discount to book value.
- 01/12/2023
|
Enact to Host Fourth Quarter 2022 Earnings Call February 7th
- RALEIGH, N.C., Jan. 06, 2023 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) announced it will issue its fourth quarter earnings release after the market closes on February 6, 2023. Enact will host a conference call to review fourth quarter 2022 financial results on February 7, 2023 at 8:00 a.m. (ET).
- 01/06/2023
|
Enact Holdings, Inc. (ACT) Q3 2022 Earnings Call Transcript
- Enact Holdings, Inc. (NASDAQ:ACT ) Q3 2022 Earnings Conference Call November 2, 2022 8:00 AM ET Company Participants Daniel Kohl - Vice President of Investor Relations Rohit Gupta - President & Chief Executive Officer Dean Mitchell - Chief Financial Officer & Treasurer Conference Call Participants Mihir Bhatia - Bank of America Bose George - KBW Geoffrey Dunn - Dowling & Partners Operator Good morning and welcome to the Enact's Third Quarter Earnings Call. Please be advised that today's conference is being recorded.
- 11/05/2022
|
Enact Holdings, Inc. (ACT) Q3 Earnings Surpass Estimates
- Enact Holdings, Inc. (ACT) delivered earnings and revenue surprises of 31.46% and 0.09%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- 11/01/2022
|
Will Enact Holdings, Inc. (ACT) Beat Estimates Again in Its Next Earnings Report?
- Enact Holdings, Inc. (ACT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 10/20/2022
|
Enact to Host Third Quarter 2022 Earnings Call November 2nd
- RALEIGH, N.C., Oct. 07, 2022 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) today announced it will issue its third quarter earnings release after the market closes on November 1, 2022. Enact will host a conference call to review third quarter 2022 financial results on November 2, 2022 at 8:00 a.m. (ET).
- 10/07/2022
|
Enact Holdings: Keeping The Shareholder Returns Coming
- The mortgage purchase origination market is facing real headwinds with rising interest rates and rising home prices. Private mortgage insurance is well shielded due to low customer churn. Many homeowners have locked in low mortgage rates and are unlikely to make a change.
- 09/09/2022
|
JPMorgan downgrades Discover Financial, Rocket Mortgage, Enact Holdings as it eyes interest rate hikes
- JPMorgan Chase analysts on Tuesday cut their ratings on three consumer finance companies after Federal Reserve Chairman Jerome Powell signaled the central bank's determination to continue hiking interest rates.
- 09/06/2022
|
Enact Holdings, Inc's (ACT) CEO Rohit Gupta on Q2 2022 Results - Earnings Call Transcript
- Enact Holdings, Inc. (NASDAQ:ACT ) Q2 2022 Earnings Conference Call August 2, 2022 8:00 AM ET Company Participants Daniel Kohl – Vice President of Investor Relations Rohit Gupta – President and Chief Executive Officer Dean Mitchell – Chief Financial Officer and Treasurer Conference Call Participants Mihir Bhatia – Bank of America John Kilichowski – Credit Suisse Tommy McJoynt – KBW Geoffrey Dunn – Dowling & Partners Rick Shane – JPMorgan Ryan Gilbert – BTIG Operator Good morning, and welcome to the Enact Second Quarter 2022 Earnings Conference Call. All participants will be in listen-only mode.
- 08/02/2022
|
Enact to Host Second Quarter 2022 Earnings Call August 2nd
- RALEIGH, N.C., July 08, 2022 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) today announced it will issue its second quarter earnings release after the market closes on August 1, 2022. Enact will host a conference call to review second quarter 2022 financial results on August 2, 2022 at 8:00 a.m. (ET).
- 07/08/2022
|
Enact Holdings: A Little Slice Of The Mortgage Pie
- The combined impact of inflation and rising interest rates are taking the air out of the housing market as home prices remain elevated and mortgages are much more expensive. In the beginning phase of a down cycle for housing, valuations on mortgage insurance providers have already dropped well below book value.
- 06/18/2022
|
Enact Holdings, Inc. (ACT) CEO Rohit Gupta on Q1 2022 Results - Earnings Call Transcript
- Enact Holdings, Inc. (NASDAQ:ACT ) Q1 2022 Earnings Conference Call May 4, 2022 8:00 AM ET Company Participants Daniel Kohl - Vice President of Investor Relations Rohit Gupta - President and Chief Executive Officer Dean Mitchell - Chief Financial Officer and Treasurer Michael Derstine - Chief Risk Officer Conference Call Participants Rick Shane - JPMorgan Doug Harter - Credit Suisse Bose George - KBW Geoffrey Dunn - Dowling & Partners Mihir Bhatia - Bank of America Ryan Gilbert - BTIG Operator Hello, and welcome to Enact's First Quarter Earnings Call. Please be advised that today's conference is being recorded.
- 05/07/2022
|
Enact to Host First Quarter 2022 Earnings Call May 4th
- RALEIGH, N.C., April 05, 2022 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) today announced it will issue its first quarter earnings release after the market closes on May 3, 2022. Enact will host a conference call to review first quarter 2022 financial results on May 4, 2022 at 8:00 a.m. (ET).
- 04/05/2022
|
Genworth Financial Schedules Earnings Conference Call For May 4th
- RICHMOND, Va.--(BUSINESS WIRE)--Genworth Financial Schedules First Quarter Earnings Conference Call For May 4th
- 04/05/2022
|
Donald Smith & Co. Plunges Into Textainer Group
- Donald Smith & Co. released this week its fourth-quarter portfolio, revealing that its top trades included boosts to its holdings of Textainer Group Holdings Ltd. ( TGH , Financial), Kinross Gold Corp. ( KGC , Financial) and Enact Holdings Inc. ( ACT , Financial) as well as reductions to its positions in American National Group Inc. ( ANAT , Financial) and Alcoa Corp. ( AA , Financial).
- 02/08/2022
|
Enact Holdings, Inc.'s (ACT) CEO Rohit Gupta on Q4 2021 Results - Earnings Call Transcript
- Enact Holdings, Inc.'s (ACT) CEO Rohit Gupta on Q4 2021 Results - Earnings Call Transcript
- 02/02/2022
|
Is Enact Holdings, Inc. (ACT) Outperforming Other Finance Stocks This Year?
- Here is how Enact Holdings, Inc. (ACT) and AllianceBernstein (AB) have performed compared to their sector so far this year.
- 01/11/2022
|
Enact to Host Fourth Quarter 2021 Earnings Call February 2nd
- RALEIGH, N.C., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) today announced it will issue its fourth quarter earnings release after the market closes on February 1, 2022. Enact will host a conference call to review fourth quarter 2021 financial results on February 2, 2022 at 8:00 a.m. (ET).
- 01/06/2022
|
Enact Holdings: ACT And Buy
- Enact Holdings: ACT And Buy
- 11/30/2021
|
Enact Holdings, Inc. (ACT) CEO Rohit Gupta on Q3 2021 Results - Earnings Call Transcript
- Enact Holdings, Inc. (ACT) CEO Rohit Gupta on Q3 2021 Results - Earnings Call Transcript
- 11/03/2021
|
Enact Mourns the Death of Board Member General Raymond T. Odierno
- RALEIGH, N.C., Oct. 12, 2021 /PRNewswire/ -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) mourns the passing of its Board Member, General Raymond T.
- 10/12/2021
|
Enact to Host Third Quarter 2021 Earnings Call November 3rd
- RALEIGH, N.C., Oct. 8, 2021 /PRNewswire/ -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) today announced it will issue its third quarter earnings release after the market closes on November 2, 2021.
- 10/08/2021
|
Genworth Financial Schedules Earnings Conference Call For November 3rd
- RICHMOND, Va., Oct. 8, 2021 /PRNewswire/ -- Genworth Financial, Inc. (NYSE: GNW) today announced it would issue its earnings release containing third quarter results after the market closes on November 2, 2021.
- 10/08/2021
|
Enact Announces Board of Directors
- RALEIGH, N.C., Sept. 29, 2021 /PRNewswire/ -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) today announced the composition of the Board of Directors, recently formed with Enact's initial public offering, which closed on September 20, 2021.
- 09/29/2021
|
Enact Receives Ratings Agencies Upgrades from Fitch, Moody's and S&P
- RALEIGH, N.C., Sept. 27, 2021 /PRNewswire/ -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) a leading provider of private mortgage insurance through its insurance subsidiaries, today announced that ratings agencies have made several updates to various ratings and outlooks for the company and its core insurance subsidiary, Genworth Mortgage Insurance Corporation (GMICO).
- 09/27/2021
|
Enact Announces Closing of Initial Public Offering
- RALEIGH, N.C., Sept. 20, 2021 /PRNewswire/ -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) today announced the closing of its initial public offering (IPO).
- 09/20/2021
|
U.S. IPO Weekly Recap: The Fall IPO Market Is In Full Swing With An 11 IPO Week
- The IPO market was full steam ahead this past week as 11 IPOs came to market.
- 09/18/2021
|
Enact Holdings Refiles For U.S. IPO
- Enact Holdings Refiles For U.S. IPO
- 08/20/2021
|
U.S. IPO Week Ahead: Mortgage Insurance And Cross-Border E-Commerce Lead A 7 IPO Week
- Seven IPOs are slated to raise $1.6 billion in the week ahead, led by private mortgage insurance company Enact Holdings (ACT). Cross-border e-commerce platform Global-E Online (GLBE) plans to raise $360 million at a $4.0 billion market cap.
- 05/08/2021
|
Enact Holdings Proposes $497 Million IPO Terms
- Enact Holdings has filed proposed terms for a $497 million IPO as it seeks to separate from parent firm Genworth Financial.
- 05/05/2021
|
5 Vice ETFs For Safe Investment In Sin Stocks
- It's been an uneven year for sin stocks. But investors are optimistic that 2021 will be better, and these vice ETFs are great for exposure.
- 11/09/2020
|
Master Class In Cannabis Investing, Part 1 (Podcast Transcript)
- We cover many fundamental questions in this deep, broad and colorful conversation with two terrific SA authors and investors in the cannabis space: James V.
- 09/14/2020
|
Master Class In Cannabis Investing, Part 1 (Podcast)
- We cover many fundamental questions in this deep, broad and colorful conversation with two terrific SA authors and investors in the cannabis space: James V.
- 09/09/2020
|
The Stoner Side Of Cannabis (Podcast Transcript)
- Many companies try and get away from the stoner side of cannabis; Scott Sundvor and Space Coyote lean into it.
- 09/06/2020
|
The Stoner Side Of Cannabis (Podcast)
- Many companies try and get away from the stoner side of cannabis; Scott Sundvor and Space Coyote lean into it.
- 09/02/2020
|
Trulieve: The Confidence That Profit Brings (Podcast Transcript)
- Trulieve recently reported earnings and is getting a lot of shareholder love - we take a deeper dive into the numbers in a frank conversation with CEO Kim Rivers.
- 08/31/2020
|
Unpacking Terpenes & Cannabinoids (Podcast Transcript)
- Everyone agrees that cannabis in the 21st century is far different than cannabis of the past - much of that has to do with terpenes.
- 08/30/2020
|
Trulieve: The Confidence That Profit Brings (Podcast)
- Trulieve recently reported earnings and is getting a lot of shareholder love - we take a deeper dive into the numbers in a frank conversation with CEO Kim Rivers.
- 08/27/2020
|
Unpacking Terpenes & Cannabinoids (Podcast)
- Everyone agrees that cannabis in the 21st century is far different than cannabis of the past - much of that has to do with terpenes.
- 08/26/2020
|
Cannabis Industry Just Needs Capital (Podcast Transcript)
- We're in a 'small business crisis' - now is the time to pick up distressed assets. Matt Hawkins, founder of Entourage Effect Capital, joins the show to discuss opportunities for distressed investing, why this time has been great for the cannabis industry and drifting towards real growth opportunities in edibles and liquids.
- 08/25/2020
|
Cannabis Industry Just Needs Capital (Podcast)
- We're in a 'small business crisis' - now is the time to pick up distressed assets. Matt Hawkins, founder of Entourage Effect Capital, joins the show to discuss opportunities for distressed investing, why this time has been great for the cannabis industry and drifting towards real growth opportunities in edibles and liquids.
- 08/19/2020
|
ESG Investing: Growing Popularity In Focus
- ESG investing has experienced a recent surge in popularity. The pandemic has offered an opportunity for ESG to show a strength seen previously during the GFC.
- 08/18/2020
|
AdvisorShares Vice ETF: Sin Stocks With A Unique Angle
- Traditionally, alcohol and tobacco stocks have performed best out of all sectors. As such, it might make sense to buy an ETF concentrated in these sorts of holdings.
- 08/18/2020
|
Limitless Potential Of Cannabis (Podcast Transcript)
- Drs. Ethan Russo and Dale Hunt, superstars in the cannabis space, join the show to discuss why the cannabis plant is a biochemical treasure trove that we've only just begun to understand.
- 08/16/2020
|
3 Charts That Suggest Sin Stocks Are Headed Higher
- Spending on leisure and vice has remained high in recent months, making this sector one to watch during this period of uncertainty.
- 08/04/2020
|
Cannabis Stocks: Once In A Generation Opportunity - No Hyperbole (Podcast Transcript)
- Cannabis stocks are a good deal right now - don't be afraid to put more money in. That's what Ted Waller, esteemed Seeking Alpha contributor, 50 year market veteran and cannabis investor says.
- 07/26/2020
|
Cannabis Stocks: Once In A Generation Opportunity - No Hyperbole (Podcast)
- Cannabis stocks are a good deal right now - don't be afraid to put more money in. That's what Ted Waller, esteemed Seeking Alpha contributor, 50 year market veteran and cannabis investor says.
- 07/22/2020
|
Truly Profitable Cannabis (Podcast Transcript)
- Talk to most successful cannabis investors and one of their top picks is likely to be Trulieve, the leading medical cannabis company in Florida.
- 07/19/2020
|
Truly Profitable Cannabis (Podcast)
- Talk to most successful cannabis investors and one of their top picks is likely to be Trulieve, the leading medical cannabis company in Florida.
- 07/15/2020
|
Importance Of Education In CBD Market (Podcast Transcript)
- Mike Donnelly is a former Navy SEAL who, with his wife Claudia, founded a hemp-derived CBD company focused on giving back to the veteran community.
- 07/12/2020
|
Cannabis Investors Should Be Looking For Good Stewards Of Capital (Podcast Transcript)
|
Cannabis Investors Should Be Looking For Good Stewards Of Capital (Podcast)
- How do you know which cannabis stocks to buy? Nicholas Gastevich, one of SA's best commenters and an experienced cannabis investor with his family firm, helps g
- 07/01/2020
|
Sustainability, Regeneration And Profit (Podcast Transcript)
- Uruguay was the first country to legalize cannabis and where Kevin Nafte and Andrea Krell, married co-founders of YVY Life Sciences, decided to plant their sust
- 06/28/2020
|
Sustainability, Regeneration And Profit (Podcast)
- Uruguay was the first country to legalize cannabis and where Kevin Nafte and Andrea Krell, married co-founders of YVY Life Sciences, decided to plant their sust
- 06/24/2020
|
Consistent Revenue Growth On The Path To Profitability (Podcast Transcript)
- As the cannabis industry matures, investors are looking for companies that are either already profitable (only a couple fit the bill) or at least on the right p
- 06/21/2020
|
Consistent Revenue Growth On The Path To Profitability (Podcast)
- As the cannabis industry matures, investors are looking for companies that are either already profitable (only a couple fit the bill) or at least on the right p
- 06/17/2020
|
Edited Transcript of ABBV earnings conference call or presentation 1-May-20 1:00pm GMT
- Q1 2020 Abbvie Inc Earnings Call
- 05/01/2020
|
AbbVie's (ABBV) Q1 Earnings and Sales Surpass Estimates
- AbbVie (ABBV) beats on earnings and revenues in the first quarter of 2020. Shares up in pre-market trading.
- 05/01/2020
|
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
- Ap19FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...
- 05/01/2020
|
Form 8.3 - Allergan plc
- Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing
(Note
- 05/01/2020
|
Form 8.3 - Allergan plc
- FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH.
- 05/01/2020
|
AbbVie expects Allergan transaction to close in May ABBV;AGN
- AbbVie expects Allergan transaction to close in May ABBV AGN
- 05/01/2020
|
Form 8.3 - Allergan PLC
- FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing
(Note 1)
F
- 05/01/2020
|
Recap: AbbVie Q1 Earnings
- Shares of AbbVie (NYSE:ABBV) rose 1% in pre-market trading after the company reported Q1 results.Quarterly Results Earnings per share were up 13.08% over the past year to $2.42, which beat the estimate of $2.25.Revenue of $8,619,000,000 up by 10.10% from the same period last year, which beat the estimate
- 05/01/2020
|
Crossmark Global Holdings Inc. Grows Stock Position in Allergan plc (NYSE:AGN)
- Crossmark Global Holdings Inc. grew its position in Allergan plc (NYSE:AGN) by 0.8% during the 1st quarter, HoldingsChannel.com reports. The fund owned 16,263 shares of the company’s stock after buying an additional 128 shares during the quarter. Crossmark Global Holdings Inc.’s holdings in Allergan were worth $2,880,000 at the end of the most recent reporting […]
- 05/01/2020
|
AbbVie Reports First-Quarter 2020 Financial Results
- AbbVie (NYSE:ABBV) announced financial results for the first quarter ended March 31, 2020.
- 05/01/2020
|
Sosei Heptares Notes That Enerzair Breezhaler (QVM149) has been Recommended for Approval in the European Union for Treating Uncontrolled Asthma
- Sosei Group Corporation ("the Company"; TSE: 4565) notes that its strategic alliance partner Novartis (SWX: NOVN) announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended the approval in the European Union of Enerzair® Breezhaler
- 05/01/2020
|
The Global Scar Treatment Market is expected to grow from USD 16,482.13 Million in 2018 to USD 53,125.13 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 18.19%
- New York, April 30, 2020 -- Reportlinker.com announces the release of the report "Global Scar Treatment Market - Premium Insight, Competitive News Feed Analysis, Company.
- 04/30/2020
|
Allergan (AGN) to Report Q1 Earnings: What's in the Cards?
- On Allergan's (AGN) first-quarter conference call, investors will look for updates on the extent to which the coronavirus pandemic may have impacted sales of its products
- 04/30/2020
|
Allergan (AGN) to Report Q1 Earnings: What's in the Cards?
- On Allergan's (AGN) first-quarter conference call, investors will look for updates on the extent to which the coronavirus pandemic may have impacted sales of its products
- 04/30/2020
|
The Global Soft Tissue Allograft Market is expected to grow from USD 3,796.59 Million in 2018 to USD 6,396.08 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 7.73%
- New York, April 30, 2020 -- Reportlinker.com announces the release of the report "Global Soft Tissue Allograft Market - Premium Insight, Competitive News Feed Analysis, Company.
- 04/30/2020
|
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
- Ap19FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT.
- 04/30/2020
|
Form 8.3 - Allergan plc
- Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
KEY INFORMATION
Name of person dealing
(Note 1)
- 04/30/2020
|
|
|
Form 8.3 - Allergan PLC
- FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing
(Note 1)
F
- 04/30/2020
|
Commerzbank Aktiengesellschaft FI Lowers Stock Holdings in Allergan plc (NYSE:AGN)
- Commerzbank Aktiengesellschaft FI reduced its position in Allergan plc (NYSE:AGN) by 18.4% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 71,870 shares of the company’s stock after selling 16,182 shares during the period. Commerzbank Aktiengesellschaft FI’s holdings in Allergan were worth $12,728,000 at the end of the […]
- 04/30/2020
|
Form 8.3 - Allergan plc
- Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note
- 04/30/2020
|
BBVA USA Bancshares Inc. Purchases 1,282 Shares of Allergan plc (NYSE:AGN)
- BBVA USA Bancshares Inc. raised its position in Allergan plc (NYSE:AGN) by 72.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,046 shares of the company’s stock after buying an additional 1,282 shares during the quarter. BBVA USA […]
- 04/30/2020
|
Form 8.3 - Allergan plc
- Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing
(Note
- 04/29/2020
|
United States Hyaluronic Acid-Based Dermal Fillers Market (2018 to 2025) - Featuring Allergan, Anika Therapeutics & Croma-Pharma Among Others - ResearchAndMarkets.com
|
|
|
Cannabis Industry Cannot Be Denied (Podcast)
- Cannabis stocks have been soaring this week - obliterating short sellers and giving hope to cannabis investors after a tough year. Julia Jacobson, CEO of Aster
- 04/29/2020
|
Calamos Advisors LLC Has $67.02 Million Stock Holdings in Allergan plc (NYSE:AGN)
- Calamos Advisors LLC lifted its holdings in Allergan plc (NYSE:AGN) by 1.6% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 378,418 shares of the company’s stock after purchasing an additional 5,877 shares during the quarter. Calamos Advisors LLC owned about 0.12% of Allergan worth $67,018,000 as […]
- 04/29/2020
|
Form 8.3 - Allergan plc
- Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note
- 04/29/2020
|
Allergan plc (NYSE:AGN) Shares Purchased by ARP Americas LP
- ARP Americas LP grew its holdings in Allergan plc (NYSE:AGN) by 10.8% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 411,965 shares of the company’s stock after purchasing an additional 40,079 shares during the period. Allergan comprises approximately 4.8% of ARP Americas LP’s investment […]
- 04/29/2020
|
USA Aesthetic Devices Market - Growth, Trends, and Forecast (2020 - 2025)
- There are certain factors that are affecting the market in a positive way which include technological advancement in devices, increasing awareness regarding aesthetic procedures, rising adoption of minimally invasive devices, and increasing obese population. Earlier, anyone seeking medical assistance
- 04/29/2020
|
BRIEF-Ironwood, Allergan Receive Notices Of Allowance For Patent Applications Covering 72 MCG Dose Of Linzess
|
Announcement relating to the voluntary delisting of Allergan Notes
- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
- 04/28/2020
|
Ironwood and Allergan Receive Notices of Allowance for Patent Applications Covering 72 mcg Dose of LINZESS (linaclotide)
- Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that the United States Patent and Trademark Office (USPTO) has issued Notices of Allowance for patent applications covering the formulation of the 72 mcg dose of LINZESS® (linaclotide) and methods of using the formulation. The patent applications
- 04/28/2020
|
Buy Allergan Stock as Big Pharma’s Biggest Deal Is About to Close
- Don't let the pandemic distract your attention from a monster acquisition -- and a chance to own Allergan stock before the deal's finalized.
- 04/28/2020
|
Allergan (AGN) Earnings Expected to Grow: Should You Buy?
- Allergan (AGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/28/2020
|
Allergan (AGN) Earnings Expected to Grow: Should You Buy?
- Allergan (AGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/28/2020
|
AbbVie (ABBV) to Report Q1 Earnings: What's in the Cards?
- AbbVie's (ABBV) Q1 top line is likely to have been impacted by biosimilar competition for Humira in international markets. However, oncology drugs may have demonstrated strong growth.
- 04/28/2020
|
Form 8.3 - Allergan plc
- Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing
(Note
- 04/28/2020
|
|
|
Allergan plc (NYSE:AGN) Stake Lessened by Delta Financial Advisors LLC
- Delta Financial Advisors LLC cut its stake in Allergan plc (NYSE:AGN) by 60.5% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,205 shares of the company’s stock after selling 1,845 shares during the period. Delta Financial Advisors LLC’s holdings in […]
- 04/28/2020
|
Karuna Therapeutics Appoints Christopher J. Coughlin to its Board of Directors
- Karuna Therapeutics, Inc. (Nasdaq: KRTX), a clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with disabling and potentially fatal neuropsychiatric disorders and pain, today announced the appointment of Christopher J.
- 04/28/2020
|
Allergan plc (NYSE:AGN) Shares Sold by Duncker Streett & Co. Inc.
- Duncker Streett & Co. Inc. reduced its holdings in Allergan plc (NYSE:AGN) by 62.0% in the 1st quarter, HoldingsChannel.com reports. The firm owned 1,270 shares of the company’s stock after selling 2,072 shares during the quarter. Duncker Streett & Co. Inc.’s holdings in Allergan were worth $225,000 at the end of the most recent quarter. […]
- 04/28/2020
|
Ironwood and Allergan get notice of allowance for LINZESS patent applications IRWD;AGN
- Ironwood and Allergan get notice of allowance for LINZESS patent applications IRWD AGN
- 04/28/2020
|
The AbbVie Buyout is Not a Sure Thing for Allergan Stock Investors
- The coronavirus has completely changed the narrative regarding AbbVie’s buyout of AGN.
- 04/28/2020
|
Form 8.3 -
- FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH.
- 04/27/2020
|
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLCl
- Ap19FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...
- 04/27/2020
|
Form 8.3 - Allergan plc
- FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
KEY INFORMATION
Name of person dealing
(Note 1)
Mill
- 04/27/2020
|
BARCLAYS PLC UK Regulatory Announcement: Form 8.3 - Allergan plc - Amendment
- Ap19 FORM 8.3 - Amendment to Purchase IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEA
- 04/27/2020
|
BRIEF-Abbvie Announces Extension Of Expiration Date For Exchange Offers For Allergan Notes
|
Why You Can Buy AbbVie At a Massive Discount
- ABBV stock does not fully reflect the deep pipeline of drugs under development and the billions in future sales from two key drugs.
- 04/27/2020
|
BARCLAYS PLC UK Regulatory Announcement: Form 8.3 - Allergan plc
- Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH IN
- 04/27/2020
|
Clarius Group LLC Buys 293 Shares of Allergan plc (NYSE:AGN)
- Clarius Group LLC boosted its stake in Allergan plc (NYSE:AGN) by 16.8% in the 1st quarter, Holdings Channel.com reports. The firm owned 2,036 shares of the company’s stock after acquiring an additional 293 shares during the quarter. Clarius Group LLC’s holdings in Allergan were worth $361,000 at the end of the most recent reporting period. […]
- 04/27/2020
|
Coastal Investment Advisors Inc. Sells 858 Shares of Allergan plc (NYSE:AGN)
- Coastal Investment Advisors Inc. lessened its stake in Allergan plc (NYSE:AGN) by 31.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,855 shares of the company’s stock after selling 858 shares during the quarter. Coastal Investment Advisors Inc.’s holdings in Allergan were […]
- 04/25/2020
|
Altium Wealth Management LLC Takes Position in Allergan plc (NYSE:AGN)
- Altium Wealth Management LLC acquired a new stake in shares of Allergan plc (NYSE:AGN) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 1,228 shares of the company’s stock, valued at approximately $217,000. A number of other large investors also recently […]
- 04/25/2020
|
Capital Health Launches COVID-19 Antibody Testing Initiative
- Before the COVID-19 pandemic reached the United States, it was clear that health care workers on the front lines were at an extremely high risk for infection. As health care organizations in New Jersey and around the country confronted the crisis and began providing adequate personal protective equipment
- 04/25/2020
|
The Global Urinary Tract Infection Market is expected to grow from USD 6,449.03 Million in 2018 to USD 9,883.48 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 6.28%
- The Global Urinary Tract Infection Market is expected to grow from USD 6,449.03 Million in 2018 to USD 9,883.48 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 6.28%. Read the full report: https://www.reportlinker.com/p05871587/?utm_source=PRN The positioning of the Global Urinary
- 04/24/2020
|
- Gilead pushes back on leaked data — Could there be a coronavirus merger ban?
- 04/24/2020
|
MILLENNIUM PARTNERS, L.P. UK Regulatory Announcement: Form 8.3 - Allergan plc
- Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH IN
- 04/24/2020
|
Age-Related Macular Degeneration: Global Drug Forecast and Market Analysis to 2028
- AMD is the most common cause of significant irreversible vision loss among the elderly. Dry AMD is evidenced by atrophy of the cells lining the retina, the accumulation of debris and the death of photoreceptors near the center of the fundus. Wet AMD is characterized by the growth of abnormal blood
- 04/24/2020
|
Form 8.3 -
- FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH.
- 04/24/2020
|
Nestl reports three-month sales for 2020, provides COVID-19 update
- This press release is also available in Français (pdf) and Deutsch (pdf) Follow today's event live 14:00 CEST Investor call audio webcast Full details in Events.
- 04/24/2020
|
AbbVie: Strong Growth Ahead
- The pending $63 billion acquisition of Allergan is expected to close by summer 2020. Management expects the acquisition to produce $2 billion in synergies. ABBV
- 04/23/2020
|
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
- Ap19FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT.
- 04/23/2020
|
Form 8.3 - Allergan plc
- FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing
(Note 1)
M
- 04/23/2020
|
|
|
Drugmakers’ financial fortunes during Covid-19 may hinge on their product mix
- Analyst reports over the past few weeks have looked into what effects the Covid-19 pandemic could have on drugmakers' sales, examining multiple factors. But virtual launches and telemedicine could mitigate some market challenges.
- 04/23/2020
|
Csenge Advisory Group Has $257,000 Holdings in Allergan plc (NYSE:AGN)
- Csenge Advisory Group lifted its holdings in shares of Allergan plc (NYSE:AGN) by 17.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,450 shares of the company’s stock after buying an additional 219 shares during the period. Csenge Advisory Group’s […]
- 04/23/2020
|
North America Skin Aesthetic Devices Market to 2027 - Regional Analysis and Forecasts by Product ; Treatment ; End User ; and Country
- The skin aesthetic devices market in North America is expected to reach US$ 2,025. 88 million in 2019; it is projected to grow at a CAGR of 11. The growth of the North American skin aesthetic devices market is mainly attributed to the factors such as increasing number of minimally invasive skin aesthetic
- 04/22/2020
|
Global Artificial Tears Industry
- Artificial Tears market worldwide is projected to grow by US$457.1 Million, driven by a compounded growth of 3.7%. Artificial Tears, one of the segments analyzed and sized in this study, displays the potential to grow at over 3.7%. The shifting dynamics supporting this growth makes it critical for businesses
- 04/22/2020
|
Were Hedge Funds Right About Allergan plc (AGN)?
- We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]
- 04/22/2020
|
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
- Ap19FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT.
- 04/22/2020
|
Form 8.3 - Allergan plc
- Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing
(Note
- 04/22/2020
|
|
|
AbbVie Gets FDA Nod for Imbruvica+Rituxan in First-Line CLL
- AbbVie's (ABBV) regulatory application seeking label expansion of Imbruvica as a first-line treatment for chronic lymphocytic leukemia in combination with Roche's Rituxan gets approval from the FDA.
- 04/22/2020
|
TherapeuticsMD Further Strengthens Board with Appointment of New Independent Director
- On behalf of the Board of Directors of TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women’s healthcare company, Chairman Tommy G. Thompson today announced the appointment of Karen L. Ling to the Company’s Board of Directors.
- 04/22/2020
|
BRIEF-Allergan PLC Says On April 21 Sent A Notice To Its Directors And Its Officers
|
Emergent BioSolutions Appoints Dr. Karen L. Smith as Chief Medical Officer
- Emergent BioSolutions Inc. (EBS) today announced the appointment of Dr. Karen L. Smith, M.D., Ph.D. as chief medical officer with responsibility for leading and further establishing Emergent’s global integrated capability in clinical development, medical affairs, and regulatory affairs. Dr. Smith and
- 04/21/2020
|
Allergan’s Acquisition by AbbVie Will Close Soon. Why One Analyst Just Downgraded Its Stock.
- SunTrust Robinson Humphrey analyst sees potential upside in the shares of Allergan but also risk if the deal with AbbVie falls through.
- 04/21/2020
|
8 Safe High-Yield Dividend Stocks Offering 5% or More
- Steep market declines in 2020 have not only been brutal on returns; they've also presented income investors with a conundrum. The market is suddenly flooded with a glut of high-yield dividend stocks, but dividends in general are less safe than they've been in more than a decade.The S&P; 500 has
- 04/21/2020
|
Form 8.3 -
- FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH.
- 04/21/2020
|
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
- Ap19FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...
- 04/21/2020
|
MILLENNIUM PARTNERS, L.P. UK Regulatory Announcement: Form 8.3 - Allergan plc
- FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERES
- 04/21/2020
|
Outlook Therapeutics Bolsters Clinical and Commercial Expertise with Two Key Appointments to Board of Directors
- Outlook Therapeutics, Inc. (OTLK) (the “Company”), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved ophthalmic formulation of bevacizumab for use in retinal indications, today announced it has bolstered its Board of Directors with the appointments of Prof. Dr.
- 04/21/2020
|
Global Antidepressants Market (2020 to 2030) - COVID-19 Implications and Growth
- Dublin, April 21, 2020 -- The "Antidepressants Global Market Report 2020-30: Covid 19 Implications and Growth" report has been added to ResearchAndMarkets.com's.
- 04/21/2020
|
Allergan downgraded to Hold from Buy at SunTrust AGN;ABBV
- Allergan downgraded to Hold from Buy at SunTrust SunTrust AGN ABBV
- 04/21/2020
|
Allergan downgraded to Hold from Buy at SunTrust AGN
- Allergan downgraded to Hold from Buy at SunTrust SunTrust AGN
- 04/21/2020
|
Edge Wealth Management LLC Has $67,000 Stock Holdings in Allergan plc (NYSE:AGN)
- Edge Wealth Management LLC decreased its stake in Allergan plc (NYSE:AGN) by 99.1% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 375 shares of the company’s stock after selling 41,190 shares during the period. Edge Wealth Management LLC’s holdings in Allergan […]
- 04/21/2020
|
Adverum Biotechnologies Appoints Ophthalmology Industry Veteran Scott Whitcup, M.D. to Board of Directors
- Adverum Biotechnologies, Inc. (ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced the appointment of Scott Whitcup, M.D. to the Company’s Board of Directors. “We are delighted to welcome Scott to our board,” said Patrick Machado, J.D
- 04/20/2020
|
Buy AbbVie Stock as the Drugmaker Diversifies Its Pipeline
- With a major acquisition in the works, ABBV stock isn't just a dividend king, but a rapidly-diversifying juggernaut.
- 04/20/2020
|
Global Biosimilars Market Study 2020 - Key Players Investing in Creating a Biosimilar of Insulin; Promoting Competition Among Various Manufacturers
- The "Biosimilars Market Global Report 2020-30" report has been added to ResearchAndMarkets.com's offering.
- 04/20/2020
|
Insights into the Worldwide Antidepressants Industry to 2030 - Identify Growth Segments for Investment - ResearchAndMarkets.com
- The "Antidepressants Global Market Report 2020-30: COVID 19 Implications and Growth" report has been added to ResearchAndMarkets.com's offering.
- 04/20/2020
|
AbbVie Analyst Upgrades Stock To Outperform, Looks Forward To 2021
- AbbVie Inc (NYSE: ABBV) shares already discount much of the risk emanating from the COVID-19 crisis, according to an analyst at RBC Capital Markets.The AbbVie Analyst Randall Stanicky upgraded AbbVie from Sector Perform to Outperform and increased the price target from $79 to $93.The AbbVie Thesis Even
- 04/20/2020
|
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
- Ap19FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT.
- 04/20/2020
|
|
|
MILLENNIUM PARTNERS, L.P. UK Regulatory Announcement: Form 8.3 - Allergan plc
- Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH IN
- 04/20/2020
|
BRIEF-Abbvie Announces Extension Of Expiration Date For Exchange Offers For Allergan Notes
|
AbbVie Announces Extension of Expiration Date for Exchange Offers for Allergan Notes
- AbbVie Inc. (NYSE:ABBV) ("AbbVie") announced today the extension of the expiration date of the offers to exchange (each, an "Exchange Offer" and, collectively, the "Exchange Offers") any and all outstanding notes of certain series issued by Allergan Finance, LLC ("Allergan
- 04/20/2020
|
Knight Announces the Re-Launch of Trelstar in Canada
- Knight licensed the exclusive rights to commercialize Trelstar® in Canada from Debiopharm, a Swiss-based, global biopharmaceutical company. “We are excited to re-launch Trelstar®,” said Jonathan Ross Goodman, Chief Executive Officer of Knight.
- 04/20/2020
|
Alembic Pharma share price up over 3 after USFDA tentatively approves conjunctivitis-related drug
- The company has total 120 ANDA approvals (107 final approvals and 13 tentative approvals) from USFDA.
- 04/20/2020
|
Farmers & Merchants Investments Inc. Reduces Position in Allergan plc (NYSE:AGN)
- Farmers & Merchants Investments Inc. cut its holdings in shares of Allergan plc (NYSE:AGN) by 0.6% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 15,590 shares of the company’s stock after selling 99 shares during the quarter. Farmers & […]
- 04/19/2020
|
CENTRAL TRUST Co Sells 524 Shares of Allergan plc (NYSE:AGN)
- CENTRAL TRUST Co lessened its holdings in shares of Allergan plc (NYSE:AGN) by 6.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,516 shares of the company’s stock after selling 524 shares during the period. CENTRAL TRUST Co’s holdings in Allergan were […]
- 04/19/2020
|
Nwam LLC Sells 1,680 Shares of Allergan plc (NYSE:AGN)
- Nwam LLC cut its position in Allergan plc (NYSE:AGN) by 36.4% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,932 shares of the company’s stock after selling 1,680 shares during the quarter. Nwam LLC’s holdings in Allergan were worth $519,000 at the end of […]
- 04/18/2020
|
10 of the Best Blue-Chip Stocks to Buy for 2019
- The best blue-chip stocks for 2020. When investors think of blue-chip stocks, they think of tried and true, large companies with entrenched businesses. They think of robust cash flows, healthy financials ...
- 04/17/2020
|
2020 Biosimilars Market Insights with a Review of 2015-2019 - ResearchAndMarkets.com
- The "Biosimilars Market Global Report 2020-30" report has been added to ResearchAndMarkets.com's offering.
- 04/17/2020
|
|
|
The World Market for Geriatric Medicines, 2020-2025 - Key Players are Endo Pharmaceuticals, Merck & Co, AstraZeneca, Pfizer and Allergan
- The "Geriatric Medicines Market - Growth, Trends, and Forecast (2020-2025)" report has been added to ResearchAndMarkets.com's offering.
- 04/17/2020
|
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
- Ap19 FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT.
- 04/17/2020
|
Form 8.3 - Allergan plc
- FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing
(Note 1)
M
- 04/17/2020
|
Outlook on the Worldwide Digestive Enzymes Industry to 2030 - Understand Customers Based on the Latest Market Research Findings
- Dublin, April 17, 2020 -- The "Digestive Enzymes Market Global Report 2020-30" report has been added to ResearchAndMarkets.com's offering. The global digestive.
- 04/17/2020
|
Global Geriatric Medicines Market Report 2020: Growth, Trends and Forecast to 2025 - ResearchAndMarkets.com
- The "Geriatric Medicines Market - Growth, Trends, and Forecast (2020-2025)" report has been added to ResearchAndMarkets.com's offering.
- 04/17/2020
|
Global Fibromyalgia Therapeutics Industry
- New York, April 17, 2020 -- Reportlinker.com announces the release of the report "Global Fibromyalgia Therapeutics Industry" -.
- 04/17/2020
|
10 of the Best Stocks to Buy for 2020
- The 10 best stocks to buy for 2020. The 2010s were kind to the average Wall Street investor; the era ended as the first uninterrupted full-decade bull market in history. Going into 2020, the U.S. economy ...
- 04/16/2020
|
AbbVie: Powerful R&D Portfolio Backing Strong Shareholder Returns
- AbbVie has an impressive R&D portfolio that will back impressive shareholder returns. The company's Allergan acquisition is almost done. The company is focused
- 04/16/2020
|
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
- Ap19FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT.
- 04/16/2020
|
MILLENNIUM PARTNERS, L.P. UK Regulatory Announcement: Form 8.3 - Allergan plc
- FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERES
- 04/16/2020
|
Outlook on the Worldwide Oral Biologics & Biosimilars Industry to 2030 - Featuring Novartis, Rani Therapeutics & Eli Lilly and Co Among Others - ResearchAndMarkets.com
- The "Oral Biologics & Biosimilars Market Global Report 2020-30" report has been added to ResearchAndMarkets.com's offering.
- 04/16/2020
|
Form 8.3 -
- FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH.
- 04/16/2020
|
Global Oral Biologics & Biosimilars Market Global Report (2020 to 2030) - Identify Growth Segments for Investment
- Dublin, April 16, 2020 -- The "Oral Biologics & Biosimilars Market Global Report 2020-30" report has been added to ResearchAndMarkets.com's offering. The.
- 04/16/2020
|
Ellevest Inc. Has $32,000 Position in Allergan plc (NYSE:AGN)
- Ellevest Inc. grew its position in Allergan plc (NYSE:AGN) by 233.3% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 180 shares of the company’s stock after buying an additional 126 shares during the quarter. Ellevest Inc.’s holdings in Allergan were worth $32,000 as […]
- 04/16/2020
|
UroGen Gets FDA Nod for Low-Grade Upper Tract Urothelial Cancer Drug
- The FDA on Wednesday approved a drug developed by UroGen Pharma to treat low-grade upper tract urothelial cancer, which rarely spreads but often recurs
- 04/15/2020
|
Inhalation & Nasal Sprays Generic Drugs Market Research Report by Indication, by Age Group, by Class, by Route, by Distrubution Channel - Global Forecast to 2025
- New York, April 15, 2020 -- Reportlinker.com announces the release of the report "Inhalation & Nasal Sprays Generic Drugs Market Research Report by Indication, by Age.
- 04/15/2020
|
The Global Thyroid Eye Disease Treatments Market is expected to grow from USD 211.49 Million in 2019 to USD 344.18 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 8.45%
- New York, April 15, 2020 -- Reportlinker.com announces the release of the report "Thyroid Eye Disease Treatments Market Research Report by Drug, by Route of Administration, by.
- 04/15/2020
|
Form 8.3 -
- FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH.
- 04/15/2020
|
Reprogrammed skin cells restore sight in mouse models of retinal disease
- Researchers led by the National Eye Institute developed a new technique that they believe could be used to restore photoreceptors in the retina that are lost to diseases like age-related macular degeneration. Rather than using stem cells—a popular approach—they turned skin cells directly into photoreceptors.
- 04/15/2020
|
Form 8.3 - Allergan plc
- Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
KEY INFORMATION
Name of person dealing
(Note 1)
- 04/15/2020
|
Gofen & Glossberg LLC IL Sells 593 Shares of Allergan plc (NYSE:AGN)
- Gofen & Glossberg LLC IL trimmed its holdings in shares of Allergan plc (NYSE:AGN) by 5.7% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,872 shares of the company’s stock after selling 593 shares during the period. Gofen & Glossberg […]
- 04/15/2020
|
Gateway Investment Advisers LLC Increases Stake in Allergan plc (NYSE:AGN)
- Gateway Investment Advisers LLC increased its position in shares of Allergan plc (NYSE:AGN) by 37.2% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 29,056 shares of the company’s stock after buying an additional 7,882 shares during the period. Gateway Investment Advisers LLC’s holdings in […]
- 04/15/2020
|
Capital Investment Advisors LLC Reduces Holdings in Allergan plc (NYSE:AGN)
- Capital Investment Advisors LLC lowered its position in shares of Allergan plc (NYSE:AGN) by 2.0% during the first quarter, HoldingsChannel reports. The firm owned 5,209 shares of the company’s stock after selling 104 shares during the period. Capital Investment Advisors LLC’s holdings in Allergan were worth $923,000 as of its most recent SEC filing. Other […]
- 04/15/2020
|
2020 Pipeline Insights on Acute Bacterial Skin and Skin Structure Infections - Collaborations, Licensing, Mergers and Acquisition, Funding & Designations
- Dublin, April 15, 2020 -- The "Acute Bacterial Skin and Skin Structure Infections - Pipeline Insight - 2020" drug pipelines has been added to ResearchAndMarkets.com's.
- 04/15/2020
|
The Global Tissue Expander Market is expected to grow from USD 1,223.13 Million in 2018 to USD 1,857.12 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 6.14%
- The Global Tissue Expander Market is expected to grow from USD 1,223.13 Million in 2018 to USD 1,857.12 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 6.14%. Read the full report: https://www.reportlinker.com/p05871688/?utm_source=PRN The positioning of the Global Tissue Expander
- 04/15/2020
|
Insights on the Worldwide Optic Nerve Disorders Treatment Industry to 2027 - Featuring Allergan, Novartis & Pfizer Among Others - ResearchAndMarkets.com
|
Worldwide Aesthetic Lasers and Energy Devices Industry to 2025 - Featuring Allergan, Bausch Health & Cutera Palomar Medical Technologies Among Others - ResearchAndMarkets.com
- The "Aesthetic Lasers and Energy Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.
- 04/14/2020
|
Davidson Kempner Capital Management LP : Form 8.3 - Allergan PLC
- Ap19FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...
- 04/14/2020
|
